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Cholinergic transmission has been studied in the presence of a
pure polypeptide toxin, of known amino-acid sequence, from cobra
venom. For the frog sartorius myoneural junction, micropipette
electrodes and on-line computer were used to show that the toxin
specifically and irreversibly inactivates postsynaptic acetylcholine
(ACh) receptors 0 Raja and Torpedo electroplaques also show nicotinic
pharmacology and were similarly affected by the toxin. The toxin
failed to affect the muscarinic receptors of the isolated frog heart
or the receptors of Aplysia neurons (neither nicotinic nor muscarinic)o
These and other observations suggest that the toxin's pharmacological
specificity is confined to nicotinic ACh receptors.
Further studies were conducted with the frog myoneural
junction. At concentrations greater than 10-8 M, the toxin irreversibly
inactivated receptors with first-order kinetics. The rate constant
for inactivation increased linearly with the toxin concentration near
the receptors.
Micro-ionophoretic application of two reversible agonists, ACh
and carbamylcholine (Carb), focally protected receptors against bath­
applied toxino Bath-applied Carb and d-tubocurarine (dTC) (a
reversible antagonist) also protected against bath-applied toxin.
Since the reversible agonists and antagonists are known to bind to
the ACh receptor, these observations suggest that cobra toxin also
binds directly to the receptor. Choline protects only at high
concentrations, in agreement with its known weak effects on ACh
receptors.
Quantitative studies of protection were evaluated according
to a simple scheme of transitions among available, reversibly blocked,
and irreversibly blocked receptors. All agonists cause desensiti­
zation, and each desensitized receptor was completely protected
against the toxin. Agonists also caused departures from first-order
iv
kinetics of receptor inactivation; these are explained by the
transition scheme and known rate constants for desensitization.
Protection by dTC, however, was less than would be expected if
curarized receptors were completely inaccesible to the toxin.
Desensitized and curarized receptors therefore have different
vulnerability to the toxin; this suggests that agonists and





















- diffusion constant for a substance within the muscle
- d-tubocurarine
- endp1ate potential
- quanta1 content (see Martin, 1966)
= 1.
number of stimuli









- miniature endp1ate potential
- miniature postsynaptic potential
- postsynaptic potential
- time constant for receptor inactivation (see p. 51).
- concentration of x.
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CHAPI'ER I
HISTORICAL BACKGROUND
We Need New Tools to Study Chemical Synapses
The synapse's function is to transmit nerve signals from a
sensory receptor cell to a neurone, from one neurone to another, or
from a neurone to a muscle fiber or other effector cell. At a
chemical synapse, the presynaptic impulse causes the presynaptic
terminal to release a small amount of chemical neurotransmitter.
This transmitter induces changes in the postsynaptic cell's trans­
membrane pot�ntial, thereby influencing its impulse activity.
The chemical synapse is one of the important tools which the
nervous system uses to integrate information. Every advance in our
understanding of synaptic transmission may contribute to the
ultimate goal of comprehending nervous function and development.
At cholinergic synapses, a starring role is played by the
membrane-bound acetylcholine "receptor" (first termed a "receptive
substance" by Langley, 1906). The receptor transforms the presence
of acetylcholine (ACh) molecules into changes in the ionic permeability
of a postsynaptic membrane. The diversity of acetylcholine's action
presumably arises because many functionally different ACh receptors
occur in nature, and we begin by cataloguing these differences in the
next two sections. In the following section (Structure-Function
Relations at the Acetylcholine Receptor), we discuss possible
features of receptor structure which allow the same molecule--acetyl­
choline--to produce different postsynaptic effects. Next (Elapid and
Hydropheid Snake Venom Neurotoxins ..• ), we consider the bases for
hoping that cobra toxin (and homologous polypeptides) will prove
useful in isolating the ACh receptor--a long-sought goal. Finally
(Choice of Preparations), we outline how the concepts of this chapter




Drugs and toxins have often advanced our knowledge of synaptic
transmission, as in Claude Bernard's classical studies of curare.
With purely electrophysiological techniques, I have studied the
curarelike postsynaptic action of a protein toxin from cobra venom.
This toxin now takes its place as a chemical probe for research on
cholinergic transmission.
The Acetylcholine Receptor: Drug Recognition
and Ionic Permeation
In this section, we describe how ACh produces its diverse
effects on nerve and muscle membranes.
The Recognition Function: Nicotinic and Muscarinic Receptors
The receptor's first function is to recognize ACh molecules. Verte­
brate ACh receptors apparently perform this task in at least two
different ways, because cholinergic agonists (see p. 6 ) fall into
two overlapping groups, depending on the receptors they excite. The
same classification of receptors serves to describe susceptibility to
antagonists (see po 6). Receptors are categorized as '�icotinic"
or "muscarinic," depending on the agonists and antagonists to which
they show sensitivity. The terminology was introduced by Dale (1914).
Studying the pharmacology of the peripheral nervous system, he first
described the distinction between muscarine's action, '�roadly repro­
ducing the effects of the cranial and sacral involuntary nerves, and
readily paralyzed by atropine," and a "nicotine" action, "reproducing
the effects of stimulating voluntary and preganglionic sympathetic
nerves, and paralyzed by curare."
It required decades to complete the evidence that ACh is in
fact the normal transmitter at all these muscarinic and nicotinic
synapses (reviewed by Dale, 1937). Known nicotinic and muscarinic
agents have since grown quite numerous, and many of the compounds
have clinical use (see, for instance, Goodman and Gilman, 1965).
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The Permeation Function: Depolarizing and Hyperpolarizing
Ionic Currents Experimenters using intracellular microelectrode
techniques have shown that ACh produces most of its effects by
transiently increasing the postsynaptic membrane's permeability to
ions (reviewed by Ginsborg, 1967). This second action of the receptor
is thought to take place very close to the site of ACh binding.
Ionic movements can influence the postsynaptic cell's activity either
by excitation, due to depolarizing currents, or by inhibition due to
hyperpolarizing currents. The direction of postsynaptic currents
depends on the specific ions involved. Excitatory ACh receptors at
the vertebrate skeletal myoneural junction produce increases in Na+
and K+ permeability (Takeuchi and Takeuchi, 1960). The postsynaptic
current therefore drives the transmembrane potential toward a
depolarized value (about -15 mv) between the Nernst equilibrium
potentials for Na+ and K+.
Inhibitory ACh receptors, on the other hand, produce K+
currents (Trautwein et al., 1956). Inhibitory CI currents have also
been detected at noncholinergic synapses (reviewed by Eccles, 1964).
Equilibrium potentials for K+ and Cl- are more negative than the
resting potential (except possibly during the action of an electro­
genic sodium pump); hence, inhibitory postsynaptic potentials (IPSPs)
hyperpolarize the membrane.
It is worthwhile emphasizing that the distinction between in­
hibitory and excitatory receptors fails to correspond to the
nicotinic-muscarinic dichotomy. Both inhibitory and excitatory
muscarinic receptors occur. For instance, application of ACh mimics
vagal stimulation of the heart by decreasing the strength and
frequency of contractions (Hunt and Taveau, 1906; Dale, 1914); but
ACh also enhances activity of the walls of the alimentary canal
(Dale, 1914). Only excitatory nicotinic receptors have been described
thus far.
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Invertebrate ACh receptors: Recognition and Permeation The
general concepts of a "recognition" and a "permeation" function, which
we have used to describe vertebrate ACh receptors, also apply to
invertebrates. In this section, we consider these mechanisms and
their variations.
A good deal of pharmacological and biophysical information has
been gathered for the ACh receptors on molluscan ganglionic neurones.
Furthermore, recent studies on the cellular localization of choline
acetylase and acetylcholinesterase in the Aplysia abdominal ganglion
(Giller and Schwartz, 1971a,b) support the notion that ACh is a
natural neurotransmitter. With these results as a background, I chose
Aplysia for my studies on cobra toxin and invertebrate ACh receptors.
A brief review of molluscan ACh receptors, with special emphasis on
Aplysia, will be presented here.
The recognition function shows some degree of variation among
molluscan ACh receptors. As in the case of vertebrates, this diversity
manifests itself in the range of cholinergic drugs which evoke or
block postsynaptic currents. Tauc and Gerschenfeld (1962) and
Strumwasser (1962) first showed that ACh hyperpolarizes some cells
and inhibits others in the Aplysia abdominal ganglion. High concen­
trations of d-tubocurarine (dTC) inhibit both responses, but hexa­
methonium antagonizes only the depolarizing responses. Eserine sulfate
also has different effects on the excitatory and inhibitory receptors
(Tauc and Gerschenfeld, 1962).
In the pleural ganglion, pharmacological variation has been
described in connection with a two-component cholinergic IPSP
(Kehoe, 1967). Both components are produced by ACh and carbamyl­
choline; however, other nicotinic (nicotine, propionylcholine,
tetramethylammonium) or muscarinic (methacholine and oxotremorine)
agonists (see p. 6 ) produce only the early phase. Antagonists are
similarly selective. The early phase is blocked by dTC or strychnine;
the late component can be blocked by tetraethylammonium (Kehoe, 1969).
5
Very similar properties have been described for a two-component
response in the abdominal ganglion (Pinsker and Kandel, 1969;
Kehoe and Ascher, 1970).
These results suggest that the distinction between nicotinic
and muscarinic receptors, which applies to vertebrates, has little
use for describing the recognition function in molluscan ACh
receptors. Perhaps the most common pharmacological test for verte­
brates involves sensitivity to atropine (muscarinic receptors) or
to dTC (nicotinic). However, where it has been tested, atropine
inactivates Aplysia ACh receptors as well as dTC (Tauc and
Gerschenfeld, 1962; Pinsker and Kandel, 1969). The drugs block only
at concentrations some two orders of magnitude higher than required
for vertebrate muscarinic (atropine) and nicotinic (dTC) receptors.
Thus, despite the fact that atropine and dTC block Aplysia ACh
receptors, the sensitivity and selectivity are much less than in
vertebrate nervous systems. Although the recognition mechanism in
molluscs shows interesting variations, we cannot classify these
variations according to nicotinic and muscarinic categories.
The ionic permeation mechanisms also show a great deal of
variety in molluscan cholinergic receptors; the ions involved--Na+,
K+, and Cl --seem to be the same as for vertebrates (for reviews,
see Ginsborg, 1967; Blankenship et �., 1971). Permeability changes
involving Cl can lead either to depolarizating or hyperpolarizing
currents, depending on the resting potential and on the intracellular
Cl concentration (see discussion of Nernst potential, p. 3 ; Frank
and Tauc, 1964). Both IPSPs and excitatory postsynaptic potentials
(EPSPs) do in fact normally occur with Cl currents, and the direction
of current flow does depend upon intracellular Cl in Aplysia (Kehoe,
1967; Blankenship et al., 1971) and in other molluscs (Kerkut and
Meech, 1966; Chiarandini and Gerschenfeld, 1967; Chiarandini et al.,
1967).
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Another hyperpolarizing response to ACh in Aplysia involves
+
outward K currents. This is the late component of the dual
inhibition described above (the early component is a Cl current)
(Kehoe, 1967).
Thus, Aplysia and other molluscs employ a wide range of
recognition and permeation mechanisms in order to generate cholinergic
+
In addition to Cl -dependent EPSPs, Na -dependent EPSPs have
been described in Aplysia (Blankenship et al., 1971; Kerkut and Meech,
1966).
Agonists, Antagonists and Desensitization In addition to the
muscarinic-nicotinic classification, cholinergic drugs may conveniently
be grouped according to whether they evoke postsynaptic currents
themselves, or block the currents produced by other drugs. The first
group are the agonists (also called activators, or cholinomimetics);
the second group, the antagonists (or inhibitors, or cholinolytics).
It is thought that most antagonists in clinical use (d-tubo­
curarine, gallamine, atropine, and others) interfere with the receptor's
recognition function. However, agonists themselves usually produce
a phase of antagonism after acting on receptors for extended periods
of time; and this action may involve interference with the permeation
function.
The phase of antagonism produced by agonists is called
desensitization. This process has received careful study at the
vertebrate myoneural junction, and for this case every agonist
produces desensitization.
Invertebrate ACh receptors also show desensitization (Tauc
and Bruner, 1963; Bennett, 1971), although considerably fewer
facts are known about the phenomenon. Agonists and antagonists and
models for their action receive excessive attention in Chapter V.
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Colinergic Actions Probably Unrelated to the Receptor
Acetylcholinesterase Acetylcholine is hydrolyzed by acetyl­
cholinesterase, a membrane-bound enzyme whose function seems to be
rapid termination of acetylcholine's transmitter action. Drugs such
as prostigmine show anticholinesterase activity at concentrations
which do not affect ACh receptors. Other drugs, such as carbamylcholine
(Carb) , are nearly as effective as ACh itself in activating both
nicotinic and muscarinic receptors, but these drugs completely resist
hydrolysis by acetylcholinesterase. Such observations show that
different structural features determine acetylcholine's recognition
by the ACh receptor and its hydrolysis by acetylcholinesterase.
Diffusion Barriers to Cholinergic Drugs Some operational dis­
tinctions among cholinergic drugs derive from mechanisms secondary to
direct membrane actions. For instance, both dihydro-�-erythroidine and
dTC block transmission at the myoneural junction; when applied syste�
ically, only dihydro-�-erythroidine blocks the motoneuron-Renshaw cell
synapse (Eccles et al., 1954, 1958). However, micro-ionophoretic
applications of dTC do block this synapse (Curtis and Eccles, 1958).
It appears that systemically applied dTC is excluded from these
synapses by an extracellular permeability barrier between the blood
and the extracellular fluids of the central nervous system (Davson,
1957). An additional diffusion barrier seems to exist in the immediate
vicinity of the Renshaw cell. This barrier lengthens the excitatory
action of ACh by delaying its diffusion away from the postsynaptic
membrane (Curtis and Eccles, 1958).
Other Effects on Membranes Acetylcholine may participate
directly in other neural membrane processes. It has been postulated
(reviewed by Nachmansohn, 1970) that ACh molecules help to activate
the Na+ and K+ permeabilities underlying the nerve impulse. The
evidence is mainly indirect: nerve axons sometimes show anticholin­
esterase activity, and antagonists such as dTC sometimes interfere
with axonal transmission.
Actions of ACh and cholinergic drugs on presynaptic membranes
have been suggested for two systems: the myoneural junction (reviewed
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by Riker and Okamoto, 1969) and sympathetic ganglionic transmission
(reviewed by Burn, 1963). Investigators do not agree on the direction
of this postulated presynaptic effect. Some experiments show that
ACh enhances further ACh release (Koelle, 1962), while others show a
marked depression (Ciani and Edwards, 1963; Hubbard and Yokota, 1964).
Structure - Activity Relations at the
Acetylcholine Receptor
The Bis-quaternary Ammonium Compounds An early attempt to
correlate structure with function of cholinergic drugs centered around
the bis-quaternary ammonium compounds, introduced by Barlow and Ing
(1948) and by Paton and collaborators (reviewed by Paton and Zaimis,
1952). These drugs have the general formula, (CH3)3N(CH2)nN(CH3)3.
Decamethonium (n=lO) is an agonist at the myoneural junction and thus
blocks by desensitization. At autonomic ganglia, decamethonium has
very little potency but pentamethonium (n=5) and hexamethonium (n=6)
become very potent antagonists. However, the mechanism is now
competitive inhibition of the receptor, similar to that caused by d­
tubocurarine.
Paton and Zaimis (1952) asked whether these drugs could help
to explain some molecular aspects of cholinergic transmission.
Perhaps the activity peaks in the bis-onium series represent the
distance between neighboring ACh receptors in the nicotinic or
ganglionic postsynaptic membrane. However, the flexibility of these
chains, and their relative lack of structure, prohibit us from
drawing further conclusions. "The literature is full of shipwrecks in
the quicksands of 'structure - action - relationship,' and it is
obvious that our biophysical knowledge is inadequate to the pharma­
cological strains placed upon it." (Paton and Zaimis, 1952). We
shall briefly summarize several recent attempts to explore this
same "structure - action relationship."
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Covalent Reactions at the Receptor Rang and his colleagues
(Gill and Rang, 1966; Rang and Ritter, 1969) synthesized several
decamethonium derivatives, including an irreversible alkylating agent
(diphenyldecamethonium mustard). In the chick biventer cervicis and
in leech muscle, these compounds seem to act with greater potency if
they are applied at the same time as carbachol or succinylcholine.
This potentiation has been termed the "metaphilic" effect, and it may
arise from molecular changes in the receptor during desensitization.
Another approach, that of Karlin and his associates, started
with the use of a two-step chemical procedure for modifying the
receptor in Electrophorus electroplaques (Karlin and Bartels, 1966).
A reduction with dithiothreitol, reversible by any of several oxidizing
agents, was followed by irreversible alkylation with maleimide
derivatives. Some maleimide derivatives caused inactivation of the
receptors; others produced permanent depolarization (Karlin and
Winnik, 1968; Silman and Karlin, 1969). From the structures involved,
Karlin (1969) deduced that a negative subsite and a sulfhydryl group
in the receptor decreased their separation from 12� in the inactive
state to 9� in the active state. Karlin also employed a tritiated
maleimide derivative (Karlin et al., 1970) as an affinity label for
counting receptors. Unfortunately, the label seems only partially
specific for the ACh receptor, because only partial protection occurs
with cholinergic agents. Nevertheless, the "specific" fraction
appears to involve about as many bound label molecules per electro­
plaque as there are acetylcholinesterase molecules.
Cooperative Interactions The concept of macromolecular systems
as sites for regulatory and cooperative interactions has been applied
to the Electrophorus acetylcholine receptor by Changeux and Podleski
(1968). The underlying principle here is that the shape of the dose­
response curve for depolarizing drugs gives a clue to the stoichiometry
of binding and the mechanisms of activation. In some cases the
addition of cholinergic activators changes the shape of the curve from
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sigmoid to hyperbolic, indicating a significant but unknown change
in the mechanisms of activatione
Conformational Analysis Another approach to the molecular
nature of ACh receptors has been to analyze the conformation of known
cholinergic drugs. The basic assumption here is that examination of
a series of drugs--particularly those of rigid structure--with similar
potency will reveal certain constancies in molecular structure; these
necessary features presumably are complementary to binding sites on
the receptor. Beers and Reich (1970) concluded that the nicotinic
receptor exploits the quaternary ammonium moiety and the carbonyl
oxygen; the muscarinic receptor, on the other hand, interacts with
the quaternary ammonium, the ester oxygen, and the methyl group.
Similar conformational analyses resulted in the estimation of a range
of bond angles and lengths essential for nicotinic (Chothia and
Pauling, 1970) and muscarinic (Baker et al., 1971) activity. In this
connection it has been emphasized that acetylcholine's conformation
in the crystal is only one of several energetically possible states.
In 1952, Paton and Zaimis found little basis for developing a
theory to "account for the way in which a drug such as decamethonium
or hexamethonium can select, from the protean manifestations of
acetylcholine action, that of endplate stimUlation or of ganglion
competition alone." Perhaps the theories advanced since 1952 will
help to accomplish this task. Its completion will bring the
mechanistic dream of Helmholtz, Ludwig, Du Bois-ReymonQ, and BrUcke
one step closer to fruition.
These and other molecular aspects of drug-receptor interactions
have been treated in several recent reviews and symposia (Danielli
et al., 1970; Andersen and Jansen, 1970; Porter and O'Connor, 1970;
Triggle et al., 1971).
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Elapid and Hydropheid Snake Venom Neurotoxins May Bind
Irreversibly to Acetylcholine Receptors
Elapid (cobras, mambas, sambas, corals) and hydropheid (sea
snake) venoms contain a variety of proteins which act on cell membranes.
These agents include cardiac muscle depolarizers, hemolytic factors,
neurotoxins, anticholinesterases, and phospholipase A. However, it
has been known for about a century that these snakes kill their prey
primarily because the venom interferes with neuromuscular functions
(see reviews by Meldrum, 1965bj Jim�nez-Porras, 1968). This section
shall summarize modern chemical and electrophysiological studies with
the toxins responsible for this interference--the "curariform" toxins.
It is £irst worth noting briefly, however, that the cardiac
muscle depolarizers and the hemolytic factors show close similarities,
both in size and in amino-acid sequence, to the curariform toxin
(D. Eaker, personal communication). We might therefore hope that an
understanding of the curariform toxin's action will have some relevance
to membrane processes in general.
It is also parenthetically interesting that Bungarus multicinctus,
and possibly o� snakes, produce an additional neuromuscular toxin.
This agent apparently acts presynaptically by interfering with the
ACh release mechanism (Chang and Lee, 1963; Lee and Chang, 1966),
thus blocking normal transmission. Called �-bungarotoxin, the toxin
molecule is several times larger than the curariform toxin in the
same venom (Hamaguchi et al., 1968).
Chemical Properties The curariform toxins have a molecular
weight of 6,000 to 8,000, depending on the species (see below); other
physical properties show little variation among species (reviews by
Jimenez-Porras, 1968; Lee, 1970). They are all strongly basic, having
isoelectric points greater than 10, and are stable to heat treatments
which destroy other toxin components of the venom. The toxins contain
large amounts of cystine, the maintenance of whose disulfide bonds
seems vital for toxicity. The toxins are readily water soluble.
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Their behavior during analytical ultracentrifugation suggests that
they are simple monomolecular spheres (Karlsson et al., 1966; Botes
and Strydom, 1969), although dimers form under certain conditions
(Karlsson et al., 1971).
Data now are available on the amino acid sequence of homologous
toxins from different species. Two subclasses of toxins exist
(Table I). One group consists of 61 or 62 amino-acid residues cross­
linked by four disulfide bonds; the second group has 71 to 74 residues
and five disulfide bonds. Within each group and between the two
groups, the toxins show extensive similarities in their sequences.
Fig. I-I shows the sequence of toxin T3 from Naja naja siamensis
(kaouthia) venom; I used this toxin in my studies.
Lack of Three-Dimensional Information In their native confor­
mation (disulfide bonds intact), the toxins are fairly resistant to
the action of proteolytic enzymes. This fact has hindered attempts
to locate the disulfide bonds and to gain other structural information.
The clustering of basic amino-acid residues prompted the suggestion
(Eaker and Porath, 1967; Yang et al., 1969) that positions 26 thru 40
of the 61-amino residue version contain the active site. However,
when the sequence of the 7l-residue Naja naja siamensis toxin was
determined, this putative active site did not appear.
It seems clear that we must await a knowledge of the three­
dimensional and disulfide bond structure in order to determine the
stereochemistry of the toxin's action. The most promising route to
this goal is probably X-ray crystallography.
Physiological Studies We may distinguish stages in the
specificity of studies on elapid and hydropheid curariform toxinse
In the first step, investigators began using defined fractions of
venom to isolate the neuromuscular blocking component. The physio­
logical assays usually consisted simply of noting that death came
from respiratory failure, but in vitro studies have appeared. For
example, Carey and Wright (1961) employed the rat phrenic nerve-
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Table I
Curariform toxins from elapid and hydropheid snake venoms, grouped
according to the number of amino-acid residues and disulfide bonds
Snake Toxin (trivial name) Reference

























Yang et al., 1969
Karlsson et aI, 1966Toxin Q'
Toxin Q' Botes and Strydom, 1969
Tami ya et al ,.; 1970
(Peaks 3, 5) Porath, 1966
Toxins Q', � Botes, 1970
Erabutoxins a,b,c Tamiya and Arai, 1966
Laticotoxin a Tamiya et al., 1967
Laticotoxin a Sato et al., 1969
Ee Karlsson, S. Kadin,
D. Eaker, (in prepara­
tion)











Toxin Q' Botes, 1970
Toxin T Karlsson et a1., 1971
Toxins T3, T4 Karlsson � al., 1971
K. Narita, C.Y. Lee
(unpublished)
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Naja naja siarnensis toxin T3
1
H-ILE ARG CYS PHE ILE THR PRO ASP ILE THR SER LYS ASP CYS PRO ASN GLY HIS VAL CYS TYR THR LYS
THR TRP CYS ASP ALA PHE CYS SER ILE ARG GLY LYS ARG VAL ASP LEU GLY CYS ALA ALA THR CYS PRO THR VAL
71
LYS THR GLY VAL ASN ILE GLN CYS CYS SER THR ASP ASN CYS ASN PRO PHE PRO THR ARG LYS ARG PRO-OH
Figure I-I. The amino-acid sequence of Naja naja siamensis (kaouthia)
toxin T3 (D. Eaker and H. Arnberg, in preparation).
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diaphragm preparation. Chang and Lee (1963) also used this prepara­
tion and the frog rectus abdominus, chick biventer cervicis nerve­
muscle, and guinea-pig ileum. Tamiya and Arai (1966) employed the
frog sciatic -sartorius and rectus abdominus preparations.
Protection by Cholinergic Agents Such studies with isolated
organs produced an important piece of information� Dimethyltubocurarine,
applied simultaneously with crude Bungarus multicinctus (Chang, 1960)
or Naja naja atra (Su, 1960) venom, protects the frog rectus abdominus
muscle against the venom's effects. A similar protection was observed
against the pure toxins in the chick biventer cervicis muscle (Lee and
Chang, 1966; Eu et al., 1967). Since curarine binds to the ACh
receptor (Jenkinson, 1960), this suggests that the venoms also exert
their action by such binding. Chapter V deals with extensions of
these observations.
Electrophysiological Studies A second stage of specificity was
attained with the recording of postsynaptic depolarization rather than
muscle tension (Peng, 1960; Meldrum, 1965aj Change and Lee, 1966).
These experiments confirmed that isolated polypeptide components of
elapid venoms block acetylcholine's depolarizing action at the
skeletal myoneural junction. Chapter III treats this action in
greater detail.
Autoradiography with 1311 Toxin In addition to the protection
experiments with curare, another line of evidence also suggests that
elapid toxins bind directly and irreversibly to the ACh receptor.
The pure curariform toxins from Bungarus multicinctus (Lee and Tseng,
1966), Naja naja (Tseng et a1., 1968), and Laticauda semifasciata
(Sato et al., 1970) were labeled with 1311; mice were killed by
injections of the labeled toxin. Autoradiography of the diaphragm
showed that the label remained only at the endplate region. When
rats received injections of labeled bungarotoxin 60 days after
severance of the phrenic nerve, the label spread out over the whole
length of the muscle fibers (Lee et al., 1967). This distribution of
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label conforms to the spread of receptors after denervation
demonstrated electrophysiologically (Thesleff, 1960; Miledi, 1963)
and autoradiographically with l4C-curarine (Waser and LUthi, 1957;
Waser, 1960).
Choice of Preparations
The preceding section reviews the evidence that cobra toxin
blocks the vertebrate myoneural junction. In my experiments, I sought
to locate this action at the ACh receptors themselves and to determine
which receptors are susceptible to the toxin.
Frog Myoneural Junction This preparation has interested
scientists since the time of Volta and Galvani. Claude Bernard used
The working hypothesis, that only nicotinic receptors would
show sensitivity, arises from two lines of evidence. First, there are
no reports that the toxin blocks noncholinergic transmission.* Second,
a-bungarotoxin fails to block muscarinic transmission in the guinea
pig ileum (Chang and Lee, 1963).
With this evidence as a background, I chose at least one synapse
from each of three groups: nicotinic, muscarinic, and molluscan (not
assignable to either category, see p. 5 ).
it to localize the site of curare action; Helmholtz and Adrian chose
it to investigate impulse conduction.
More recently, frog muscles were employed by Ling and Gerard
(1949), Nastuk and Hodgkin (1950), Fatt and Katz (1951), Nastuk (1953),
and del Castillo and Katz (1955), who pioneered the use of glass-
*Parnas and Russell (1967) found that crude elapid venoms interfered
with crustacean neuromuscular transmission. However, these effects
were reversible with low venom concentrations and probably arose from
nerve blockage, which was caused by toxins different from the
curariform component.
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tipped microelectrodes for intracellular recording and for micro­
application of drugs.
The frog myoneural junction now offers the best opportunity to
study the biophysics and pharmacology of nicotinic transmission.
Hence, I employed this preparation for most of my experiments. My
biophysical techniques represent only minor improvements on the
methods of the authors cited above, although advances in electronic
technology have provided instruments of greater stability and
computer technology has enhanced the capabilities of on-line and
off-line processing systems (Methods).
Skate Electroplaque The tails of all skates (Raja) contain
weak electric organs of unknown function. These organs are embry­
onically related to muscle. It is therefore not surprising that
synaptic transmission to electroplaques shares many characteristics
with neuromuscular transmission. These features include nicotinic
pharmacology, as shown by sensitivity to dTC (Brock and Eccles, 1952).
Postsynaptic potentials (PSPs) are increased by anticholinesterase
(Grundfest and Bennett, 1961). The reversal potential for the
postsynaptic current is about equal to that for the endplate current.
Furthermore, spontaneous miniature PSPs and quantization of the PSP
have been noted, and the quantitative Ca++ dependence of ACh release
is similar to that at the myoneural junction (Lester, 1970c). In
view of these similarities, I thought it worthwhile to compare cobra
toxin's action in this preparation with its effect on neuromuscular
transmission.
Torpedo nobiliana Electroplaques The electroplaques of the
giant electric ray, Torpedo nobiliana, are classically known to exhibit
nicotinic pharmacology, as shown by sensitivity to curare.
Theyprovide a less convenient electrophysiological preparation
than Raja electroplaques. The cells are large, thin discs, in which
intracellular penetrations are difficult to maintain and whose cable
properties do not allow PSPs to sum for the entire cell. Furthermore,
18
pharmacological investigations are difficult because bath-applied
agents fail to penetrate past the surface cells (see Chapter III).
Nevertheless, Torpedo electric organs contain so much ACh
receptor material that they may provide suitable material for
biochemical studies. For this reason, I considered it important to
explore their response to cobra toxin.
Aplysia californica Abdominal Ganglion The recognition and
permeation functions at Aplysia and other molluscan ACh receptors have
been reviewed (pp. 4-6).
I chose an easily studied synapse in the abdominal ganglion.
The presynaptic fiber runs in the right mantle connective; the
parabolic burster (Strumwasser, 1965), also called R15 (Frazier et al.,
1967), is the postsynaptic cell. This synapse is cholinergic (F.
Strumwasser, personal communication; see also Chapter III).
Isolated Frog Heart The isolated frog heart has been used to
investigate chemical transmission ever since Loewi's studies (1921)
first established that the process occurs. The receptors are
muscarinic according to several criteria (see, for instance, Goodman
and Gilman, 1965).
The heart is also interesting because its ACh receptors produce
inhibitory K+ currents. Therefore, we can learn whether the toxin's
specificity follows the permeation rather than the recognition
function, by comparing this preparation with the excitatory muscarinic
receptors of the guinea pig ileum (Chang and Lee, 1963). The toxin's
specificity for the permeation function cannot be studied with





Frog Sartorius Myoneural Junction
Solutions For my experiments, a Ringer solution bathed the
muscle. The standard Ringer contained NaCl, 112 roM; KCl, 2.5 roM;
MgC12, 4 mM; CaC12, 2 mM; and Tris, 5 rnM (pH 7.3). It was often
desirable to decrease the quantal content to just the pOint where
no endplate potential (EPP) exceeded spike threshold in any fiber.
I accomplished this, unless otherwise stated, by decreasing CaC12 to
0.5 - 0.7 roM, with isotonic substitution of NaCl (del Castillo and
Katz, 1954a).
The experiments were performed with toxin T3 from the venom
of Naja naja siamensis - (kaouthia) (Thailand cobra), kindly supplied
as the crystalline powder by D. Eaker (Karlsson et al., 1971). The
toxin was stored at 40 in a stock concentration of about 1 mg/ml in
acetate buffer, 50 mM, pH 5.0. Concentrations were checked by
measuring a�sorption at 280 m� against a known absorbance value (1 cm
path length, 1 mg/ml) of 1.05 (D. Eaker, personal communication).
-7
The toxin solutions were diluted to stated concentrations (1.6 x 10
M, or less) in the appropriate Ringer just before use. d-Tubocurarine
chloride was obtained from K & K Laboratories, Inc.; all other organic
chemicals were supplied by Sigma.
Experimental Chamber The experimental chamber held 3 - 5 ml of
solution, depending on the fluid level. For solution changes, a dead
volume of 2 - 3 ml was introduced by the connecting tubes and bubble
traps. Studies on dye dilution showed that a solution change was 50%
complete after 10 ml, 95% after 25 ml, and more than 99% after 50 ml
had flowed through the system. Flow rates as high as 10 to 15 ml/min
could be employed, giving essentially complete changes within 5
minutes.
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Recording Recording was accomplished with glass microelectrodes
filled by boiling with 3 M KCl. Tip resistances ranged from 5 to 30
Mn. The low-resistance pipettes were preferred for single prepara­
tions involving measurements on miniature endplate potentials (MEPPs)
(Chapter III). For repeated penetrations in the same fiber over a
period of several hours, greater recording noise with the high­
resistance pipettes was accepted in return for the decreased probability
of damage to the muscle fiber membrane.
Transmembrane potentials were recorded between the microelec­
trode and an Ag-AgCl indifferent electrode located in the bath. The
recording amplifier (designed by J.P. Hervey) has been described
elsewhere (Purple, 1964)0 It consisted of an augmented follower with
bucking and polarizing circuitry plus an active bridge for measuring
resistance.
Micro-ionophoresis Glass micropipette electrodes were also
used for focal ionophoretic delivery of drugs. Since my experiments
often required the same ionophoretic dose over a time course of 1 - 2
hours (see Chapter V), several precautions insured that the iono­
phoretic pipette did not change its efficacy due to mechanical drift,
slow desensitization (del Castillo and Katz, 1955), or change in the
effective amount of drug delivered per current pulse. I monitored the
ACh or Carb potentials over an initial control period of 15 - 30
minutes; only preparations giving stable responses were used. Also,
the ACh or Carb potentials recovered within 15 minutes after relatively
strong desensitizing treatments which I initially feared might change
the characteristics of the drug pipette.
Multiple Penetrations in Experiments with Bath-Applied Drugs
For protection experiments with bath-applied drugs (Chapter V), the
goal was to overcome the variations among individual fibers (see
Results) by averaging over the results for several fibers in a single
muscle. The external recording method of Fatt (1950) was inappropriate
because in preliminary experiments the cobra toxin failed to block
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transmission to the fibers on the interior of the muscle. This
presumably occurred because the toxin did not readily penetrate past
the superficial fibers. I therefore chose to monitor the EPP in
about five identified superficial fibers over the complete experiment
(often as long as 8 hours). This was accomplished by sketching a
portion of the muscle as it appeared under the stereomicroscopej
fibers were then impaled sequentially for measurements at various
stages in the experiment. The technique has been described by
Fatt and Katz (1950).
Computerized Data Collection and Analysis
In my experiments, it was of prime importance to monitor con­
tinuously the degree of block produced by toxin or by reversible
cholinergic agents. For this purpose, two factors dictated the use
of automatic averaging rather than simply inspecting oscilloscope
traces. Firstly, fluctuations among successive responses were caused
by the quantal mechanism of ACh release (del Castillo and Katz, 1945a).
Secondly, when the treatments blocked most of the ACh receptors, EPP
amplitudes often were comparable to or smaller than the electrical
noise in the recording instruments. An additional requirement arose
from the need to measure many individual EPPs and MEPPs for the
quantal content determination (Chapter III).
On-Line Analysis: CAT An on-line digital computer provided
the necessary signal-processing capabilities (see Fig. II-I). One
goal of the CAT ("Computer of Average Transients") system was to
allow the experimenter to control the experiment without leaving the
electrically shielded room where the recording took place. In addition
to the electrophysiological equipment, the shielded room contained
timing and stimulating equipment, a digital-to-analog output scope
which displayed averaged waveforms and protocol information, and a
bank of switches for selecting among program options. The timing was
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Figure II-I. Equipment configuration for experiments with the frog
sartorius myoneural junction. Two intracellular microelectrodes
are shown supplying signals for two data channels.
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The signal path led from the electrodes and cathode followers
to the vertical signal amplifiers of an oscilloscope (Tektronix 502A).
Shielded cables carried the signals to analog-to-digital converters
in the data interference. A buffer received a single sweep of 1000
pOints (one channel, or more usually two 500-point channels). This
sweep could be written on digital tape for further analysis by the
RECAT system (see below). The CAT program added each sweep to a
thousand-point array of running sums in core storage. A new average
was then formed by dividing each point by the number of sweeps
completed. A second buffer transmitted the averaged numbers to
digital-to-analog converters in the data interface; the averaged
sweep appeared on the display scope. At the end of each averaging
series, the computer displayed the final avera�e, produced a plot
of the average, and wrote the sums and averages on tape.
Two data channels were available. These usually carried intra­
cellular potential records from two different endplates, but in some
experiments, one channel contained information on extracellular
potential or on current through an ionophoretic pipette.
The CAT system also could accept data which had been recorded
on analog tape with the proper timing signals. This arrangement was
used for analyzing simultaneous presynaptic and postsynaptic intra­
cellular potential records from the squid giant synapse (Lester, 1970a).
Off-Line Analysis: RECAT The CAT output tape provided the
input for the RECAT analysis (Fig. II-2) (actually, RECAT is an addition
to the CAT program). With human help, RECAT transformed a series of
single sweep records to an array of EPP or MEPP amplitudes on
FORTRAN-compatible tape. Each sweep was read in from magnetic tape
and appeared on the display scope, accompanied by two horizontal
"pointer" lines. The positions of these pointers were continually
controlled by two potentiometers which fed into analog-to-digital
converters 0 One pointer was set to the baseline, the other to the
























Figure 11-2. The RECAT system for analyzing EPP and MEPP data. As
explained in the text, the potentiometers control the positions of
the pointers on the display scope� The computer used these positions
to calculate response amplitudes.
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With practice, I measured records at the rate of about one
4
sweep every five seconds. A total of 6 x 10 sweeps were processed
in this fashion. A totally automatic measurement of EPP amplitudes
has since been developed utilizing new features of the computer's
FORTRAN compiler (work of Norman Milkman).
Skate Electroplaque Preparation
I used two skate species, Raja erinicea and Raja ocellata,
which are commonly available at Woods Hole. Intracellular recording
from skate electroplaques was first reported by Brock, Eccles, and
Keynes (1953) and in detail by Brock and Eccles (1958). My procedures
closely followed those of Grundfest and Bennett (1961). Segments of
electric organ about 1 cm in length were used for these studies, as
shown in Fig. 11-3.
Solutions The experimental chamber (Lester, 1970a) had a
o
volume of 0.5 ml and its temperature, usually about 15 , could be
controlled within ±0.25o• The chamber was continuously replenished
by fresh solution, at a rate of about 1 ml/min. The elasmobranch
Ringer solution (Brock and Eccles, 1958) had the following composition
(mM): NaCl, 250; KCl, 5; CaC12, 4; MgC12, 2; urea, 333.3; Na
phosphate buffer, 1.5 (pH 7.4).
Stimulating and Recording Paired silver wires, insulated
except at the ends and mounted on a micromanipulator, served as
stimulating electrodes. These were placed near nerve fibers at the
rostral end of the preparation and intracellular records were taken
from electroplaques near the caudal end. This arrangement gave the
largest possible distance between the stimulating and recording
electrodes, thereby minimizing electrical pickup in the recording
circuit.
Recording could generally be accomplished with electrodes of
about 5 Mn tip resistance; the electroplaques were large and easy
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Skate electroplaque preparation
Figure 11-3. Intracellular recording from skate electroplaques, as
described in text. Each electroplaque receives innervation from
about three presynaptic fibers (Brock and Eccles, 1957); in favorable
preparations, each input could be isolated by varying the stimulus
parameters. The test electroplaque is shown penetrated by two
microelectrodes for resistance studies (Lester, 1970c).
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photographed with a Polaroid camera.
Other techniques duplicated those described for the frog
myoneural junction.
Torpedo nobiliana Electroplaque Preparation
In Torpedo, the kidney-shaped electric organs form almost half
the mass of each wing. Each organ contains several hundred columns
of cells; the columns themselves consist of about a thousand stacked
electroplaques.
Figure 11-4 describes the techniques for stimulating the pre­
synaptic nerve and intracellular recording from individual electro­
plaques (Bennett et al., 1961). These studies employed the frog
muscle chamber (see p. 19). Solutions and all other procedures
duplicated those described for skate electroplaques.
Aplysia californica Abdominal Ganglion
Experiments on the isolated abdominal ganglion of Aplysia
californica, the sea hare, were conducted at room temperature in the
chamber used for studies on frog muscles (see p. 19). The ganglion
was bathed in artifical sea water. The right mantle connective nerve
was led off into the moist stimulating chamber which ordinarily housed
the frog motor nerve (Fig. 11-5).
A tough connective tissue capsule encases the ganglion.
Attempts to soften this sheath with pronase resulted in damage to
synaptic transmission. Penetrations could, however, be successfully
accomplished through the sheath if the rnicroelectrodes (tip resistance
5 - 19 Mn) were mounted on a micromanipulator with axial drive instead
of the usual oblique approach. This procedure gave stable intracellular









Column of electro plaques
Torpedo nobiliana electroplaque preparation
Figure II-4. Microelectrode recording from a column of Torpedo electro­
plaques. The ventral end of the column is shown. The electrode tip
could be positioned above the column (a), within (b,d), or between
(c,e) cells. The indifferent electrode (not shown) remained
stationary in the bath. The stimulating current actually excited





from dorsa I surface
Parabolic burster
( R 15 )
Aplysia cot/tom/co abdominal ganglion
Figure 11-5. Intracellular recording from an identified cell in the
Aplysia abdominal ganglion.
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Like all synapses in Aplysia ganglia, the axo-axonic junction is
some electrical distance from the cell body, which is the site of
recording. However, this PSP has a greater amplitude and faster
rising phase than most others in Rl5 and in other Aplysia neurons.
The actual synapse is probably less than one cable length from the
recording electrode.
Isolated Frog Heart
For my experiments, the heart was pinned to a layer of silicone
rubber (General Electric RTV-615) in the bottom of a dish at room
temperature. Frog Ringer solution (see p. 19) was used.
Ten ml of solution was present in the dish and just covered
the heart. Drugs were added as noted. Some of the experiments were
-5
performed in the presence of dTC, 3 x 10 w/v, in order to eliminate
any effects of the toxin on parasympathetic ganglion cells in the
heart. No differences were noted with and without dTC.
In the absence of drug treatments, the isolated heart beat
steadily for 1-2 hours. Beating frequency was measured by recording
the time required for 10 beats. In addition, I noted the relative




COBRA TOXIN BLOCKS NICOTINIC ACETYLCHOLINE RECEPTORS
Experiments with the Frog Myoneural Junction
My initial investigations with the frog myoneural junction
confined the cobra toxin's action to one locus: the postsynaptic ACh
receptor. Three lines of evidence contributed to this conclusion:
1) quantal content analyses on EPPsj 2) experiments with micro-iono­
phoretic application of ACh; 3) comparisons of EPP time course before
and after toxin application.
Quantal Content For extensive analyses on endplates treated
with cobra toxin, I utilized a toxin concentration of 1.6 x 10-8 M
with [ca++] = 0.4 mM (see Methods, Chapter II). The quantal content,
m, ranged from 1.5 to 15 but usually was near three. This value lies
in the range where three independent estimators of m may reliably be
employed (Martin, 1966): mo' from the number of failures; ml, from
the ratio of the average EPP to the mean MEPP amplitudes; and m2, from
the coefficient of variation of the EPP amplitude distribution. To
minimize errors caused by trends, the determination of m2 utilized a
grouped linear regression analysis similar to that described by Colomo
and Rahamimoff (1968).
Figure 111-1 shows results of an experiment. After a delay,
the toxin causes a decline in EPP amplitude. This decrease eventually
attains an exponential rate. A simple explanation for this finding is
that the toxin irreversibly inactivates a given fraction of the
remaining ACh receptors per unit time (mechanisms of toxin action are
treated in Chapter IV). Indeed, washing the preparation (not shown;
see Fig. IV-I) caused only slight recovery after several hours.
In Figure III-I, the curves for EPP (A) and MEPP (C) amplitude
remain parallel on semilogarithmic co-ordinates, while the curve B
(showing the quantal content, m) remains essentially constant. These
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Figure III-I. Postsynaptic action of cobra toxin on myoneural
transmission. At cross-hatching chamber was flushed with solution
containing toxin. Q,. and 0, Measurements on a series of 128 EPPs.
0, Measurements on spontaneously occurring miniature EPPs. A,
Average EPP amplitude ± s.e. EPPs without error flags at later
times were too small, relative to the recording noise, for
accurate measurements on individual responses. B, Quantal content
m ± s.e; (0) mO' computed from the number of failures; (.) m2,
computed from the coefficient of variation of the EPP amplitude
distribution; (0) ml, computed by dividing EPP by miniature EPP
ampli tudes. C, Miniature EPP amplitude; 0, measured directly.
0, computed as EPP/mO; e, computed as EPP/m2. The vertical line
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observations support the interpretation that the toxin decreases
the individual quantal size while not disturbing m, the number of
quanta released.
Non-uniform Action on Different Regio�of the Endplate Most
experiments showed a decline in m as well as a diminution in
MEFPamplitude. Figure 111-2 illustrates such results. Results from
fifteen endplates were averaged by comparing the changes in m and
in MEPP amplitude when the EPP had dropped to about one-fourth its
original amplitude. The averages (as a fraction of the value before
treatment) were EPP amplitude, .26; MEPP amplitude, .41; m, .67.
Taken at face value, these data indicate an additional pre­
synaptic action of the toxin on ACh release. Such effects have been
proposed for several other agents which act postsynaptically (see
Chapter I). In this case, however, the correct explanation seems to
arise from non-uniform postsynaptic action of the toxin on different
regions of the endplate, which can often attain lengths of 1 mID (R.
Miledi, unpublished results). This complication can naturally arise
from local variations in the accessibility of the endplate to toxin
molecules, caused by variations in the connective tissue and Schwann
cell covering (Birks et al., 1960). Also, some branches of the end­
plate may lie in the cleft between adjacent fibers, while others lie
on the more exposed superficial surface (Kilhne, 1887; Couteaux, 1947;
Cole, 1955). (A detailed treatment of diffusion barriers and binding
sides for the toxin, and their contribution to variability and
latency, is given in Chapter IV.)
The following observations suggest that such positional
differences account for sizeable variations in the time course of
toxin action. Firstly, variations as great as a factor of 3 occurred
in the delay before toxin action and in the inactivation rate constant
(slope of curve A in Fig. III-I; see Chapter IV) even when different
endplates a few hundred � apart were monitored simultaneously in the










































Figure 111-2. Data from another endplate, in which m appeared to
decline as well as
text for discussion.
MEPP amplitude. See Figure 111-1 for legend;
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factor of 100 in superficial EPPs, still allowed endplates on deep
fibers to develop EPPs larger than impuse thresholde (Also noted
by Lee and Chang, 1966.)
If the toxin acts non-uniformly along an endplate, then the
coefficient of variation of the MEPP amplitude distribution should
increas� Recording noise made it somewhat unreliable to measure this
effect. There was, however, a significant increase, from .23 during
the control period to .36 when the toxin had decreased the EPP by at
least a factor of two (fourteen endplates). This broadening tends
to lower all three estimates of m. The number of failures, which
determines mo' is overestimated because responses consisting of one
small MEPP are treated as failures. The average MEPP amplitude is
likewise underestimated as small MEPPs go undetected, thus decreasing
mI. Finally, the broadened MEPP distribution leads to a broader EPP
amplitude distribution, decreasing m2•
Higher Toxin Concentrations Figure 111-3 shows data taken from
another experiment, in 0.6 roM Ca++. Here m2 was approximately 15
(min. EPPs were not measured so ml was unknown; mo is unavailable in
this range, because no failures occur). Toxin concentration was
1.14 x 10-7 M.
Under these conditions, the behavior of the EPP amplitude
fluctuations still supports the hypothesis that the toxin acts
irreversibly on the quantal size but not on the quantal content.
With this higher toxin concentration, the delay time is short and
the action more rapid. (For a discussion of the quantitative dose­
response studies, see Chapter IV.) The average (heavy line) and
two standard deviations (lighter lines) have been marked for the
first 80 points before the toxin begins to act (segment A to B).
An exponential decline was fitted to the 120 EPPs between C and D.
Assuming that the toxin affected only the scale of the distribution,
the same fractional limits have been continued to the exponential
decline portion. Parallel lines result on the semilogarithmic plot.













Figure 111-3. EPP amplitude during treatment with toxin at a
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concentration of 1.14 x 10 M. Shaded area represents the time
required to flush the experimental chamber with the toxin solution.
EPP amplitudes greater than 1 mv have been corrected for nonlinear
summation as described by Martin (1955) (see Chapter IV).
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Therefore, the EPP amplitude distribution has not become
broader, relative to the mean, than it was before toxin treatment.
A decrease in m, however, would have increased the breadth. For
instance, the Poisson formula predicts that, if m decreased by 40%,
then 12% of the EPPs would fall outside of the limits on segment C-D.
As found in the experiments with lower toxin concentration, the
toxin seems to act only by decreasing MEPP amplitude.
Micro-ionophoretic Application of Acetylcholine The results
described above prove that cobra toxin decreases the quantal size of
ACh action at the myoneural junction. This diminution could arise
from two causes: 1) presynaptically, decreased ACh content per
quantum; 2) postsynaptically, decreased ACh sensitivity of the muscle
fiber membrane.
Figure 111-4 shows that possibility (2) is the case. ACh
++
release by the nerve depends on the presence of Ca , but the response
to micro-ionophoretically applied ACh remains substantially unchanged
when Ca++ is removed (trace B). The toxin, however, blocks both the
ACh potential and the EPP (D-F).
Note that Figure 1I1-4f seems to indicate that the ACh potential
recovers slightly with washing. It is extremely difficult to
evaluate such small changes. One might suppose that any reversibility
of the toxin's action would show up more clearly with micro-iono­
phoretic application, because the receptors accessible to the
externally applied ACh might also be washed more thoroughly (Goldsmith,
1963). However, mechanical drifts between the muscle fiber and the
ACh pipette can also cause changes of this magnitude. If any
reversibility exists, it awaits study with more appropriate techniques.
Time Course of the EPP We may eliminate other effects of the
toxin by comparing the time courses of averaged EPP waveforms before
and after treatment (Fig. 111-5). Although the absolute values of
the EPPs differ by a factor of 80, the two traces superimpose after
magnification to the same peak amplitude.





D TOXIN 12 MIN
0.5 MV E TOXlN 27 MIN
r WASH 30 MIN
4/4/70
Figure 111-4. Effect of cobra toxin on the response to micro-iono-
++
phoretically applied ACh. Control solution contained 0.6 mM Ca ;
toxin solution also contained 5 x 10-8 M toxin. ACh was applied
with a current of 15 nA for 10 msec. Brief capacitative transients
mark the beginning and end of the ACh pulse. Each trace represents




Figure 111-5. Waveforms of 128 averaged EPPs, before (smooth, heavy
trace) and 150 min after (light, noisy trace) treatment with cobra
toxin as described in the text. Waveforms have been amplified to
match peak amplitudes; actual amplitudes were 2.1 mV before, 25
�V after. Amplifier was capacitance-coupled with a time constant
of 100 ms.
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Anticholinesterases such as prostigmine prolong both the rise
and fall of the EPP (Fatt and Katz, 1951). Therefore, the toxin
appears not to affect the acetylcholinesterase. Also, the latency
between the stimulus artifact and the start of the EPP remains
unaffected; therefore, propagation of the presynaptic impulse and
synaptic delay (Katz and �ledi, 1965a, bj Lester, 1970a) do not
change significantly. Chang and Lee (1966) provided valuable evidence
on this point. They recorded the impulse at the nerve terminal and
found that it remained unchanged during treatment with cobra toxin,
while the endplate current declined. The rising phase of the EPP
appears constant, so the kinetics of ACh release have not altered
(Katz and Miledi, 1965 b, c). The constancy of the falling phase
indicates that the passive resistance and capacitance of the muscle
fiber also remain the same.
In three out of 16 endplates, the EPP after toxin treatment had
a significantly faster falling phase than during the control period.
In one of these cases, the resting potential had declined by 20 mv and
the difference was ascribed to a decreased membrane resistance; the
experiment was discarded. For the other two cases, examination of the
individual records showed that another active endplate, several cable
lengths away, was contributing to the signal during the control period.
The toxin apparently inactivated the distant endplate more quickly
than the near one in both cases.
Absence of Effects on Other Processes The resting potential
showed no significant changes for any of the toxin treatments used.
Furthermore, in 13 endplates, when the EPP had dropped to less than
half its control value, the frequency of MEPPs averaged .97 times
the control (range .48 to 1.53). Chang and Lee (1966) have Observed
no changes in the muscle fiber action potential after toxin treatment.
The foregoing observations all lead to the conclusion that the




Cobra toxin blocked cholinergic sensitivity in the skate
electroplaque. Figure 111-6 shows that both postsynaptic potentials
(PSPs) and steady depolarizations, caused by bath-applied carbachol
(Carb), decreased after toxin treatment. Like the EPP at the frog
myoneural junction, the PSP declined exponentially with time, and no
substantial recovery occurred after several hours' washing with fresh
solution.
Block of Miniature Postsynaptic Potentials The toxin also
blocked spontaneous miniature postsynaptic potentials (Lester, 1970c),
which are analogous to MEPPs at the myoneural junction. The skate
electroplaque's qualitative response to the toxin thus matches the
results of the more extensive study of the endplate.
Toxin's Potency The toxin's potency, as defined by the inacti­
vation rate constant (see Chapter IV), was about 15 times less in the
skate preparation than in the frog myoneural junction. This potency
did not vary strongly with temperature in the range 110 - 300 but the
toxin showed much less activity below 110 (see Chapter IV).
Torpedo nobiliana Electroplaque
Figure 111-7 shows that the toxin blocked PSPs in surface
electroplaques from Torpedo nobiliana electric organs. As in the
skate, there was little recovery with washing.
Lack of Penetration to Deep Electroplaques Figure 111-8, from
another preparation, shows that the toxin fails to penetrate past the
surface electroplaque. Negative-going traces recorded at locations
a and b (see Methods, Chapter II) indicate that postsynaptic currents
are still flowing into subsurface electroplaquesj and intracellular
records, such as at d, confirm that these electroplaques are still
active. At earlier times (see 17 minutes) diphasic waveforms appear
in the surface electroplaque. I ascribe these waveforms to differ­






A. Before toxin B. After toxin
6/29/70
Figure 111-6. Tracings of the skate electroplaque's resting potential
and PSP (stimulus artifact has been retouched). Dashed line shows
normal resting potential (90 mv). A few minutes prior to each
measurement, Carb (3.3 �) was added to the Ringer and caused a
steady depolarization. Trace B was taken after a 60 minute exposure




A. Control B. Toxin 2 x 10-7 M, 26 min
6/26/70












Figure III-S. Tracings of microelectrode recordings from a column
of Torpedo electroplaques. Electrode position refers to Figure
11-4. control and responses at 2 and 17 minutes after addition of
toxin were made at location b.
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and the stronger but later potential differences which arise from
postsynaptic currents in subsurface electroplaques (Bennett et al.,
1961, Fig. 5H). Similar records were obtained in a study of dTC
action in this preparation, suggesting that the smaller dTC molecule
also fails to penetrate to deep cells (Bennett et al., 1961).
Aplysia californica Abdominal Ganglion
Figure 111-9 shows that relatively high concentrations of the
toxin ( 6 x 10-7 M) applied for long time periods (5 hours in one
preparation) had no significant effect on the cholinergic PSP under
investigation. In the experiment shown in Figure 111-10, subsequent
application of dTC caused a reversible diminution of the PSP. This
confirms its cholinergic nature.
Isolated Frog Heart
The toxin had no effect on the frog heart. Figure 111-10
presents results of a typical experiment. The toxin treatment would
have decreased the ACh sensitivity at the frog endplate by several
orders of magnitude. Control applications of ACh cause a weak,
erratic heartbeat (curve A); toxin alone (B) has no effect; the
response to ACh occurs with undiminished intensity after treatment
with toxin (C).
Atropine, a muscarinic antagonist, still blocked ACh sensitivity
after toxin treatment (Curve D). Epinephrine does not act on cholin­
ergic receptors; as expected, the toxin also had no effect on this
drug's excitatory action (Curve E).
Discussion
The experiments on the frog myoneural junction show that cobra
toxin acts solely on ACh sensitivity, although in many cases the
analysis of quantal content is complicated by the toxin's non-uniform
action along an individual endplate. These results agree with the
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Ap/ysio abdominal ganglion
Parabolic burster cell (R 15 )
0.4 sec
A. Control B. After toxin 6 x 10-7 M, 2 hr
9/4/70
Figure 111-9. Tracings of PSPs in Aplysia neurones, as described in
the text.
-5
I Toxin 6 x 10-7 M
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Figure 111-10. Response of the isolated frog heart to cobra toxin
and reversible drugs, as described in the text. Test substances
were added at the vertical arrow; sUbstances written to the left
of the arrow were already present in the Ringer.
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observations of Meldrum (1965a) and of Chang and Lee (1966), who
employed the same preparation, and with studies using less specific
techniques on other vertebrate myoneural preparations (reviewed in
Chapter I).
Electroplaques show nicotinic pharmacology (see p. 17 and
review by Bennett, 1970). My results, that the toxin blocks trans­
mission in Raja and Torpedo electroplaques, provide support for the
hypothesis that the toxin acts on all nicotinic receptors.* Also,
bungarotoxin blocks transmission at Electrophorus (Changeux et al.,
1970) and Torpedo electroplaques (�ledi et !l., 1971).
The toxin has no detectable action on the frog heart, and
bungarotoxin failed to affect the guinea pig ileum (Chang and Lee,
1963). Thus, muscarinic receptors, whether inhibitory (heart) or
excitatory (ileum) show no susceptibility to the toxin. All these
facts suggest that the toxin blocks only nicotinic receptors.
This conclusion is strengthened by my observations that the
toxin fails to block a cholinergic PSP in a mollusc, Aplysia califor­
nica. These ACh receptors can be classified as neither nicotinic nor
muscarinic (see p. 5). In this connection, it would be interesting
to know the toxin's action on an invertebrate synapse which shows
nicotinic pharmacology, such as the leech myoneural junction (Flacke
and Yeoh, 1968a, b).
*
One report (Chou and Lee, 1969) is at variance with this conclusion.
Cobra toxin failed to block ganglionic transmission, either in vivo
(cat superior cervical ganglion) or in vitro (guinea pig hypogastric
nerve-vas deferens preparation), as measured by muscle tension at the
nictitating membrane or vas deferens.
Three caveats prevent the simple conclusion that ganglionic
receptors are invulnerable to the toxin. First, it was not clearly
shown that the toxin reached the vicinity of the postsynaptic receptors.
Second, the relation between ganglionic PSP amplitude and muscle
tension is unknown; intracellular postsynaptic records would be possible
and desirable. Third, autonomic ganglia show, in addition to the
nicotinic EPSP, a slow muscarinic component (Eccles and Libet, 1961)
whose mechanism is not easily explained by ionic permeation (Libet,
1970). Under certain conditions, this second EPSP reaches spike
threshold (Nishi and Koketsu, 1966; Brown, 1967). (continued)
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Finally, despite the fact that ganglionic receptors are
classified as nicotinic on the basis of their susceptibility to dTC,
their pharmacology shows significant differences from that of the
myoneural junction. One of these differences involves the members
of the bis-onium series (see po 8); others are reviewed at length
in the pharmacological literature (for instance, Goodman and Gilman,
1965). If cobra toxin can in fact distinguish between ganglionic
and myoneural ACh receptors, this action would not be unprecedented.
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CHAPTER IV
QUANTITATIVE STUDIES ON POTENCY
To explore the mechanism of cobra toxin's action, one requires
a reproducible assay for the potency of the toxin. Figure IV-I shows
the basis for such an assay.
The Inactivation Rate Constant a
As previously noted (p. 31), the toxin appears to act with
first-order kinetics, irreversibly inactivating a given fraction of
the receptors per unit time. In agreement with this mechanism,
Figure IV-I shows an exponential decline in the EPP after the chamber
is flushed with Ringer containing toxin. The decline halts, but fails
to reverse, when the chamber is flushed with toxin-free solution.
When the preparation is again subjected to the same toxin concentration,
the decline resumes with the same slope.
For this exponential decline, we may measure a time constant,
l, such that the EPP falls to lie of its original amplitude in time 1.
The slope of the descending straight line in Figure IV-I is then
proportional to a = 1/ l, and we may define a as the rate constant
for the inactivation process.
a as a Function of Toxin Concentration
Figure IV-2 shows a versus toxin concentration for 47 endplates,
each represented by a point. The lowest concentration produced
results like those shown in Figure III-I; the highest concentration
is represented by Figure 111-3.
As discussed in Chapter III, there was appreciable scatter in
a among endplates tested with the same concentration of toxin. It
will be shown in the Discussion (p. 61) that this scatter probably


























Figure IV-I. Exponential decrease in the EPP as a reproducible assay
for the cobra toxin's potency. Each point represents the average of
64 endplate potentials (EPPs), except for the last two which
represent 128. Horizontal lines represent times when chamber was







































[Toxin N.n.T3], M x 108
10 12
Figure IV-2. Potency vs. toxin concentration for 47 different endplates
measured over a one-year period. Experiments like that of Figure
IV-l were used to determine 1/ 'L.
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to reach the receptors. Nevertheless, a clearly increases with
concentration. The results fit a proportional relationship with a
6 -1 -1 4-1constant kT of approximately 3.3 x 10 min M ,or 5.5 x 10 sec-1
M (see Eq. IV-I, p. 58).
Extending the Concentration Range It would be interesting to
extend the dose-potency results to higher and lower toxin concentra­
tions than shown in Figure IV-2. At higher concentrations extra-
-1
polation predicts that a would increase to greater than 1 min
Under such conditions, my apparatus would not allow fluid changes
rapid enough to establish a steady concentration before the EPP
declined to unmeasurable levels.
-3
For lower concentrations, one extrapolates to a = 3 x 10
-1 9
min at toxin concentrations of 10- M. I have observed that a
continues to decrease as the toxin concentration decreases. However,
quantitative measurements on a become unreliable in this range,
because of several perturbing processes. For instance, the EPP
often changed in amplitude during solution changes, sometimes as much
as a factor of 2. These changes seem mainly to involve the quantal
content and may reflect mechanical stresses on the nerve terminal
(see Goldsmith, 1963). Many control preparations also showed
additional slow drifts in quanta 1 content. The much smaller decline
caused by the toxin, could not be measured against these background
processes.
Latency as a Function of Toxin Concentration
This point was not studied systematically, because the methods
for changing solutions improved gradually over the course of these
experiments. These modifications undoubtedly affected latency
measurements. Nevertheless, some observations are possible.
Let us define latency as the time from the start of the
solution change until the fractional rate of change of EPP amplitude,
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dEPP
EPP , reaches 90% of its final value. This final value is a, and
dt
we measure latency by noting the time required for the semilogarithmic
plot of EPP vs time (Figures III-I, 111-2, 111-3, IV-I) to attain
linearity. The Discussion (po 61) presents a natural basis for this
formulation in terms of diffusion processes.
At any given toxin concentration, latency varied by at least
a factor of 3, as did a. The two variables were often--but not always-­
correlated: a short latency accompanied a large a, and vice-versa.
Despite the uncertainties introduced by changing methods and by
scatter in the data, it was clear that latency decreased with increasing
toxin concentration. In FiguresIII-l and 111-2, the latencies are
about 50 min; at this toxin concentration (1.6 x 10-8 M), the range was
10-60 min. This is the lowest toxin concentration that produced
reliable latency measurements. For the highest concentration tested
(1.1 x 10-7 M; see Fig. 111-3) the range was 160 to 480 sec (average,
320 sec); the solution change required 150 sec for completion in this
case.
Temperature Dependence of a at the Skate Electroplaque
The large electroplaque cells in the skate may be penetrated
repeatedly and withstand the mechanical stresses that accompany
large temperature changes. I therefore used this preparation to study
the effects of temperature on the toxin's potency. Figure IV-3 shows
a for 15 preparations tested at constant temperatures in the range
7-3000 As with the frog myoneural junction a varied greatly among
preparations.
Decrease in a at Low Temperatures The toxin seems unable to
o
inactivate receptors below about 11. Three factors could conceivably
account for this loss of potency. First, some physical change could
















8 12 16 20
Temperature (OC)
24 28 32
Figure IV-3. Potency of the toxin vs. temperature for the skate
electroplaque. Determination of liT followed the same procedures
as for the frog myoneural junction.
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been observed in physical-chemical studies with the toxin (Chapter I).
Second, the receptor molecules might change. Some studies do show
temperature-dependent alterations in the macroscopic properties of
membranes, presumably resulting from phase changes (Ladbrooke et al.,
1968; Reinert and Steim, 1970). But there are no discontinuities in
the ACh-receptor interaction at the myoneural junction (Katz and
Miledi, 1965d; Steinbach, 1971). Finally, the extracellular tissue
near the postsynaptic membrane may change at low temperatures so as
to become impermeable to the toxin. It should be mentioned in
connection with this idea that dTC showed no large change in its
blocking activity in the skate electroplaque below 110. Assuming a
partial specific volume of 0.71 cm3/g for the toxin (Karlsson et al.,
1966), its diameter is 25 �; the longest dimension of dTC is about
15 R (Dr. H.M. Sobell, personal communication). The two molecules
thus have comparable sizes, but several types of physical barriers
would be able to distinguish between them. The origin of the 11°
cutoff remains unexplained.
Lack of Temperature Effects Above 110 The results in Figure
IV-3 are inconsistent with a QlO greater than about 1.5 in the range
12-30°. Because of the experimental scatter, however, it is
impossible to determine a more definite value for the QIO. In
Figure IV-3 a line has been drawn horizontally through the average
of all points above 120, in order to emphasize that the toxin's action
shows no marked temperature dependence.
Discussion
In this section, we first propose a simple model for the toxin's
action, then discuss the evidence for the model. The model is:
T+R TR. IV-A
58
A toxin molecule T and a receptor R form the irreversible,
inactive complex TR. This scheme leads to the differential equation:
= IV-la
where rl is the number of available receptors R (the subscript 1 is
included for consistency with Chapter V) and [T] is the toxin concen­
tration near the receptors. (It will be shown that [T] is nearly
equal to the toxin concentration in the bathing solution.) When [T]
is constant, we define
IV-lb
This chapter describes the kinetics of EPP and PSP diminution
during toxin action. Two quantitative questions merit consideration.
First, what is the relationship between the EPP (or PSP, in the skate)
and the number of available ACh receptors? Second, how does the
toxin's concentration in the synaptic cleft compare with that in the
bathing solution? After discussing these points, we shall be in a
position to examine the molecular interpretation of Scheme IV-A.
EPP as a Measure of Receptor Number The relation between dose
and response has taken on importance with the recent rise of
quantitative pharmacology; Waud's (1968) review summarizes current
methods and ideas. "Receptor occupancy" is a fundamental concept.
Consider a simple monomolecular binding of ACh to the receptor, R:
a
ACh + R .. Ach·R, IV-B
where Ach·R is the "occupied receptor" _or "ACh-receptor complex."
If a is the affinity constant for the binding, the law of mass action
implies that
[ACh·R] = srI [ACh]
1 + a [ACh]
IV-2
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Equation IV-2 has the same form as the Michaelis-Menten expression or
the Langmuir adsorption isotherm. Several lines of evidence lead to
the conclusion, for normal neuromuscular transmission, that a[ACh]« 1
(Waser, 1960; Waud, 1967; Steinbach, 1968b). Therefore, with good
accuracy,
IV-3
The number of occupied receptors is thus proportional to the ACh
concentration and to the number of available receptors.
Next, we consider the relation between receptor occupancy and
the observed effect--in this case, the EPP amplitude. Stephenson
(1956) and others have pointed out that this relation need not be a
linear one. "Spare receptors," for instance, would mean that the
response amplitude reaches saturation even though some receptors
remain in the R state.
At the frog myoneural junction, however, the only significant
nonlinear contribution to the occupancy-EPP relation arises because
depolarizations displace the electrochemical driving force for the
endplate current. In my experiments, all EPPs of greater than 1 mv






Here EPP is the corrected amplitude; EPP' represents the observed
amplitude. The driving force En is the difference between the resting
potential and the reversal potential for the endplate current; this
reversal potential is about -15 mv (del Castillo and Katz, 1954f;
Takeuchi and Takeuchi, 1959; 1960).
Katz and Thesleff (1957) observed another source of non­
linearity in the occupancy-EPP relation. They measured the depolari­
zations produced by ACh or Carb pulses from each barrel of twin
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micro-ionophoretic pipettes. They then applied the two pulses
simultaneously and obtained an depolarization whose amplitude exceeded
·the sum of those produced by the two pulses individually. This result
expresses an occupancy-EPP curve which is concave upwards, or "S­
shaped," rather than linear. The nonlinearity could arise from
several sources. First, the affinity constant, a, might vary over
the receptor population. Second, some binding site other than the
receptor could take up limited quantities of agonist (Katz and
Thesleff, 1957) (this mechanism receives more attention below, p. 63).
Finally, the cause might also be certain idiosyncracies in the method
of micro-ionophoretic application (Waud, 1967). The last explanation
seems likely because the nonlinearity fails to appear when receptor
occupancy is defined by the amount of charge transferred through the
pipette (Waud, 1967) rather than by the superposition procedure (Katz
and Thesleff, 1957). In any case, the effect is small and, following
the example of its discoverers, we shall ignore it for quantitative
analyses of receptor characteristics (Katz and Thesleff, 1957).
The EPP is, of course, not a steady potential but has a complex
waveform. Its amplitude and time course are determined by the endplate
current (Takeuchi and Takeuchi, 1959; 1960) and by the cable properties
of the muscle fiber (reviewed by Falk and Fatt, 1965). The endplate
current in turn depends upon the detailed time course of ACh acetyl­
cho1ines release from the presynaptic terminal (Katz and Miledi,
1965b, d), its diffusion, its hydrolysis by acetylcholinesterase
(del Castillo and Katz., 1955, 1957b), and the stability of the ACh·R
complex. We merely emphasize here that all these processes are also
linear with the amount of ACh, for my experimental conditions.
Our conclusion is that, upon correction with Eq. IV-4, the
following relationship holds:
EPP = v [AJrl IV-5
where V is a constant. [AJ represents the total amount of agonist
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(ACh or Carb), released either from the nerve terminal or from a
micro-ionophoretic pipette, when the time course of release remains
constant. Equation IV-5 therefore expresses the important fact that
the EPP (or drug depolarization) varies linearly both with the amount
of agonist and with the number of available receptors.
Toxin Concentrations Near the Receptors As pointed out briefly
in Chapter III (p. 34), the synaptic cleft is a complex, torturous
structure of largely unknown physical characteristics. Diffusion
processes, however, playa venerable role in biophysics. Impressive
intellects have studied the topic and their conclusions can generate
some insights on the toxin-receptor interaction •
. That the toxin concentration near the ACh receptors does not
instantaneously follow the bath concentration may be deduced from two
observations. First, a finite latency ensues between the introduction
of toxin to the bath and the first effects on the EPP in surface
fibers (Figs. III-I, 11-2, 11-3). Second, many interior fibers show
little diminution in their EPP even after EPPs in surface fibers have
been reduced by a factor of 100.
This last fact suggests a means to attack the problem. Assume
that the central plane of the muscle is a perfect sink for toxin
molecules--at least for times on the order of hours.* Let the muscle
be an infinite slab exposed to the solution at both surfaces; the
upper surface (where we impale fibers) lies at x = d, the lower
surface at x = -d. We assume for the moment that toxin molecules
undergo only diffusion within the muscle. The diffusion equation for
the steady state is given by
*Hil1 and Macpherson (1954) considered diffusion in the frog sartorius
muscle without this assumption. Their table I allows the reader to
draw conclusions very similar to the one presented here. For our
2 -4 -1
parameters, Kn equals 1.5 x 10 sec
b2
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and for [TJ =
d2 [TJ
dx2
[T J in the bathing solution, we have
o




at any distance x from the central plane. Equation IV-7 holds for
the steady state.
The approach to the steady state is described quite usefully
by Jacobs (1967, pp. 62-63). The time t required to attain 90% of the






and is independent of T •
o
the muscle (see below).
Here D is the diffusion coefficient inside
m
We now take reasonable values for the
parameters in Equations IV-7 and IV-8 and ask whether these equations
provide a good description of the kinetics of toxin action. Assuming
that Equation IV-l holds, the fractional rate of change of EPP
dEPP
amplitude, is proportional to [TJ. This rate of change is theEPP
dt
slope of a semilogarithmic plot of EPP vs. time (Figs. III-I, 111-2,
111-3, IV-I); the linearity of these plots constitutes the major
evidence for Scheme IV-A.
For the frog sartorius muscle, 2d = 0.07 cm. For molecules
ranging in size from inorganic ions (Hill and Macpherson, 1955) to
albumin (�V = 7.2 x 104) (Hill, 1964), D in the extracellular muscle
m
space is about one-fourth its value in free solution. The diminution
arises primarily from the fact that molecules must travel along complex
paths. The diffuskn constant of toxin T3 is 1.3 x 10-6 cm2/sec
-7 2
(Karlsson et aL, , 1971). Thus, D = 3.2 x 10 cm /sec.. For surface
m
fibers of diameter 0.01 cm, x lies between 0.025 and 0.035 cm.
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Then, by Equation IV-7, the steady-state value for [TJ lies
between 0.3 [T ] and [T J. Therefore, a (Eq. IV-lb) should varyo 0
by about a factor of 3, for any [T Jj this variation was in fact
o
found experimentally .. Furthermore, the largest values of a should
correspond to a local toxin concentration of [T J. This point will
o
be discussed in connection with ionophoretic ACh application (p. 64)8
The approach to equilibrium, as defined by Equation IV-S,
should require from zero to 200 seconds. For the highest toxin con­
centration tested, the observed values (see p. 55) are only slightly
longer than predicted by Equation IV-S and we conclude that, at this
concentration, no other barriers seriously limit the toxin's action.
However, latency increased with decreases in [T ], reaching a
-S
0
value of 10-60 minutes at [T J = 1.6 x 10 M (Figs. III-I, 111-2).
o
This result violates the simple diffusion scheme we have presented.
Perhaps the most straightforward modification is to include a population
of binding sites for the toxin. A likely location for the sites would
be the extracellular gel that permeates the synaptic cleft and the
channels between Schwann, nerve, and muscle cells (see discussion in
Chapter III). The binding must be reversible, because bungarotoxin
bound irreversibly to only one molecular species--presurnably the
receptor--in the studies of Miledi et al.,(197l)e
If the binding is rapid, then the mathematical analysis of
diffusion becomes equivalent to that of oxygen diffusing into a
muscle with an "oxygen debt." Hill's (192S, Eq. 55) analysis may be
adapted to give the following conclusion. Let the equilibration time
t be defined for a diffusion barrier as in Equation IV-S. Then, if
the barrier also contains binding sites y, the equilibration time t'
becomes





Equation IV-� expresses the relation, found experimentally, that
equilibration time increases as [T ] decreases. Furthermore, [yJ
-7
0
need only be of the order of 10 M to substantially alter the
equilibration time.
These conclusions about a and latency are based upon diffusion
processes. They might be tested further with micro-ionophoretic
application of ACh. Receptors thus activated are accessible to the
external solution across a negligible diffusion barrier (del Castillo
and Katz, 1955; Goldsmith, 1963; Katz and Miledi, 1965d). Therefore,
a for the toxin's action on ACh potentials should show little variation
at- a given [T ] and should not greatly exceed the largest a for EPPs.
o
Furthermore, the latency should equal the time required for solution
change 0 Preliminary experiments verify these predictions.
Our discussion of diffusion processes is now complete, and we
conclude that after the initial transient, the toxin concentration [TJ
near the receptors was nearly equal to the bath concentration [T J.o
Dropping the subscript to express the bath concentration, we have the
result that the inactivation rate constant a (Eq. IV-I) is equal to
�[TJ. From Figure IV-2,
4 -1-1
= 5.5 x 10 sec M.
Validity of these Conclusions for the Skate Electroplaque
In the skate, as in the frog, it seems that the toxin concen­
tration near the receptors was nearly equal to that in the external
fluid. In comparison with frog muscle, we know relatively little
about the diffusion properties of the organ and the biophysics of
individual electroplaques. Nevertheless, the important observation
was that the PSP declined exponentially after an initial delay
comparable to that described for frog muscle.
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It is worthwhile to note that the inactivation rate constant
a for the skate preparation was some 15 times smaller than for the
frog at the same [TJ (compare Figs. IV-2 and IV-3). This fact could
imply that the toxin had to suffer hindered access to the receptors.
However, dTC also has about ten times less potency in this preparation
than in the frog (preliminary observations). Therefore, the difference
in kT between the skate and the frog probably arises from some mole­
cular variation in the receptors themselves.
The possibility still remains, however, that the toxin loses
it effectiveness below 110 because a change occurs in the diffusion
properties of the extracellular gel, thereby preventing the toxin
from reaching the receptors (see Results, p. 56, for a full discussion).
The Toxin-Receptor Interaction Our value of kT may be compared
with the maximum possible rate constant for a reaction between a drug
molecule and a receptor. This corresponds to the encounter-controlled
reaction, in which each collision is successful and molecules react
as rapidly as they can diffuse toward each other. Burgen's treatment
(1966) has particular relevance to the drug-receptor interaction.
Suppose the receptor engulfs the toxin so that the radius of the
complex is not substantially larger than that of the toxin. Then, at
o 9 -1-1
20 , the encounter-controlled rate constant is 10 sec M • This
4
value exceeds 10 times the observed kT• We should therefore
consider processes which may modify the rate constant k. Electro­
static attraction can increase k by at most a factor of 2. However,
electrostatic repulsion, the presence of bound water or ions, and
the requirement of activation energy for combination could each
reduce k by several orders of magnitude. Since the toxin is a large
molecule, we also expect that it will probably not be able to display
all aspects to the receptor at each encounter; hence, the probability
of reaction will be reduced.
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Then k_T is the rate constant for recovery of the EPP after the toxin
is washed away. My experiments would have detected a recovery with
-5 -1
a time constant of one day. Therefore, k_T < 10 sec •
The dissociation constant for the toxin-receptor complex is
given by k_T/kT' so the dissociation constant must be less than O.� nM.
The dissociation constant for tetrodotoxin's binding to sodium channels
is about 1 nM (Hille, 1968). Therefore, cobra toxin binds to the
receptor at least as tightly as this; of course, the actual rate
constants are several orders of magnitude smaller in the case of
cobra toxin, so its action appears irreversible.
Mechanisms of Toxin-Receptor Binding� In considering Scheme
IV-A, it is worth noting that the toxin need not bind directly to R
so long as the end result is an inactive receptor. Each toxin
molecule might also bind to two or more receptor sites. This possi­
bility draws support from the fact that the toxin's calculated
diameter is 25 Ai the distance between adjacent receptors is less
than 15 A if both amine groups in dTC and decamethonium bind to
receptors (see Chapter I. Structure-Function Relations).
Could the toxin act like an enzyme? It would chemically
inactivate receptors, then diffuse away unchanged. Enzymatic
reactions, however, generally have a QIO of greater than 2. The
toxin's action, like that of dTC (van Maanen, 1950; Jenkinson, 1960),
o
has a small temperature dependence (above 11). This fact argues for
a mechanism based upon irreversible binding rather than enzymatic
. Al t t t f t d·
131 .
catalys1s. so, rea men 0 ra 1aphragm with I-bungarotox1n
(Lee and Tseng, 1966) or cobra toxin (Tseng et al., 1968) causes
)
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specific retention of the radioactivity at the endplates.
F th 1311 b . h tl b dur ermore, - ungarotox1n as recen y een use as a
specifically bound chemical marker for the isolation of the ACh
receptor from Torpedo electroplaques (Miledi et al., 1971). Since
the toxin is quite resistant to proteolysis in its native form
(see Chapter I), one doubts that only a peptide fragment remains
bound to the receptor structure.
In summary, the most likely mechanism for the toxin's action
is that it inactivates receptors by binding irreversibly to the
postsynaptic membrane. Chapter V describes experiments which
constitute a direct test of this postulated mechanism.
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CMP.rnRV
COBRA TOXIN BINDS TO ACETYLCHOLINE RECEPTORS
Rationale
Cobra toxin acts ?pecifically with low reversibility to block
nicotinic ACh receptors. At the concentrations where this action has
. -8 -7
rece1ved most study (10 M to 1.2 x 10 M), no other physiological
effects have been detected (Chapter III).
Furthermore, this toxin, and its homologous peptides in the
venoms of other elapid and hydropheid snakes, manifests no enzymatic
activity (see Chapter I). Derivatives of these polypeptides,
labeled with 1311, have been shown to bind to the endplate regions of
skeletal muscle fibers (see Chapter I).
These facts suggest that cobra toxin acts by binding specifi­
cally and irreversibly to nicotinic acetylcholine receptor sites on
postsynaptic membranes. If such binding occurs, then one should be
able to protect the receptors with other compounds--both antagonists
and agonists (see p. 6 )--which bind to ACh receptors. Furchgott
(1964) has reviewed this technique and its applications.
Such an agent is d-tubocurarine (dTC) (Jenkinson, 1960), an
antagonist. Using recordings of tension in the frog rectus abdominus
muscle, Chang (1960) found that dimethyl-dTC provided the expected
protection against crude Bungarus multicinctus venom. Similar
observations were soon made with Formosan cobra (Naja naja atra) venom
(Su, 1960). Later, it was briefly reported that dTC protected the
chick biventer cervicis muscle against the pure toxins from these
snakes (Lee and Chang, 1966; Su et al., 1967). Although protection
appeared nearly complete in these experiments, recordings of muscle
tension provide only an indirect measure of receptor activity. I
have extended these results using microelectrode techniques, and I
find that dTC protects against the toxin only at high concentrations.
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Acetylcholine itself must also bind to the ACh receptor. Several
studies have shown that carbamylcholine (Carb) acts precisely like
ACh, except that Carb is not hydrolyzed by acetylcholinesterase
(del Castillo and Katz, 1957bj Jenkinson, 1960). I report here that
these agonists protect against cobra toxin much more effectively than
does dTC. This qualitative difference probably arises from the
desensitization produced by all agonists.
The effectiveness of a protective agent should depend, to a
first approximation, on how well it binds to the ACh receptor. Like
all potent agonists and antagonists, choline contains a quaternary
ammonium group. I have therefore used choline as a control protective
agent. It seems effective only at concentrations several orders of
magnitude higher than those of dTC, ACh, or Carbo This finding is
consistent with the known weak effects of choline on ACh receptors
(del Castillo and Katz, 1957c).
Desensitization
Several investigators have described the postsynaptic response
to prolonged application of agonists either by perfusion (Fatt, 1950;
Thesleff, 1955) or ionophoretically (Katz and Thesleff, 1957).
Figure V-l illustrates the response, known as "desensitization."
When Carb is added to the bath, the membrane potential rapidly
approaches the reversal potential for ACh action. During this time,
muscle fibers twitch; hence, microelectrode penetrations are
impossible to maintain. After a few minutes, the membrane potential
begins returning to normal resting level. In this phase, the ACh
receptors no longer produce an increased ionic permeability in
response to ACh (Manthey, 1966). Consistent with this observation
is the fact that presynaptic nerve impulses no longer elicit
detectable EPPs (smaller doses of Carb do allow small EPPs to be
observed; see Figures V-6, V-7). The receptors are said to be
desensitized. A small steady-state depolarization (10-15 mv) remains
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Figure V-l. Desensitization of an endplate by Carb, and recovery.
Intracellular recordings were impossible for the first 8 minutes





in the desensitized state. This steady depolarization is probably
not due to endplate receptors (Nastuk and Gissen, 1965; Portela
et al., 1970), but occurs all along the muscle fiber. It disappears
upon washing with toxin-free Ringer. The EPP also recovers with
washing.
The time course of desensitization and rec�very depend upon
the Carb or ACh concentrations (Fatt, 1950; Katz and Thesleff, 1957;
Nastuk and Gissen, 1965; Nastuk and Parsons, 1970; Lambert and
Parsons, 1970). The Carb concentration (0.14 roM) used for the experi­
ment in Figure V-l is approximately that which existed near the
receptors in the experiments with ionophoretic ACh and Carb application
(see below, pp. 71-75). This concentration was also employed for
some experiments with bath-applied Carb as a protective agent (see
below, pp. 75-76).
Results of Experiments with Ionophoretic Pipettes
As described previously (see Chapter III), ionophoretic ACh
and Carb potentials decrease, as does the EPRwhen the preparation
is exposed to cobra toxin. Little recovery occurs upon washing with
toxin-free Ringer.
Figure V-2 depicts the results of a more complex experiment
utilizing an ACh pipette. Trace A shows a control trial with a
braking current (del Castillo and Katz� 1955; see also Chapter III)e
Trace B shows that the receptors near the ACh pipette desensitize
(see p. 70), because the ACh potential vanishes. Most of the other
receptors, however, are still active, because the EPP has not
declined substantially. During ACh application, the fiber depolarizes
by a few mV (not shown in Figure V-2). The ACh potential recovers
with the re-establishment of a braking current (2-C), and the steady­
state depolarization also disappears.
The desensitizing current is then re-applied, and several
minutes later the toxin is added to the chamber for 20 minutes. The
4MJ
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Figure V-2. Focal protection against the toxin by ACh. Procedures as
described in text. Each trace represents 16 averaged records.
Upper traces, currenttltrough ACh-pipette (dashed line denotes zero
current); lower traces, intracellular potential. Current trace has
been omitted in C-G because it is identical to A or B. Resistance
of ACh pipette increased with time, so electrical pickup in




EPP declines gradually during this period (Figure 2-D). The chamber
is then flushed with toxin-free solution, and several minutes later
the braking current is re-established. The receptors near the ACh
pipette recover from desensitization, as trace C shows.
Furthermore, the ACh potential has been substantially unaffected
by the toxin (Trace E). The EPP recovered only slightly in this
experiment. In other experiments, however, the recovery was more
substantial (Table I), and the reasons for this variation are
described below (PP. 74-75).
An important control then consists of adding the toxin in the
presence of a braking current. This repeats the experiment described
in Figure 111-4. As found previously, both the ACh potential and the
EPP decline irreversibly (Fig. V-2F, G).
Table II presents the results from four such experiments. It is
clear (1) that desensitization itself caused no consistent changes,
and (2) that desensitization protected against the toxin at least
for the receptors near the drug pipette.
Extent of Protection The extent to which desensitization
protected the whole endplate is shown by the behavior of the EPP.
This protection varied markedly. On the average, the drug potential
was protected more than the EPP, but in some cases the whole endplate
seemed protected.
These results are consistent with several idiosyncracies of
this technique. Most importantly, endplate geometries vary as to
nerve branches and folds (KUhne, 1887; Couteaux, 1947; Cole, 1955).
It is thus necessary to deduce what fraction of each endplate was
actually desensitized (and therefore protected) by the ACh and Carb
applications. Such data are in theory available from the records of
resting potential and EPP during desensitization. However, slow
drifts in voltage caused by electrode polarization, and unknown
behavior of the membrane resistance, actually make this an unreliable
Table II
Protection against cobra toxin by focal ionophoretic application of ACh and Carb. Traces from
experiment identified 4/06/70 are shown in Figure V-2o Experimental procedure is described
-8 -8
in texto Toxin concentration was 5 x 10 M (4/06/70) or 6.2 x 10 M (others).
I. Desensitization II. Protection III. No Protecti on
Identifier Protecting Drug potential, my EPP, my Drug potential, my EPP, my Drug potential, my EPP, mvdrug
Before After Ratio, Before After Ratio, After Ratio After Ratio After
Ratio After
Ratio
treatment treatment after/before after/before after/before after/before after/before after!before
4/06/70 ACh 6.5 4.8 0.74 6.5 7.1 1.09 3.5 0.73 0.6 0.085 0.3 0.09 <0.05 <0.1
4/13/70 Carb 2.5 3.5 1.4 0.9 0.6 0.67 1.2 0.34 0.25 0.42 0.07 0.06 0.03 0.1
4/17/70 Carb 5.5 5.5 1.0 1.0 1.0 1.0 13.5 2.4 0.4 0.4 1.4 0.10 0.04 0.1





practice. Some variation may also have arisen from mechanical drifts
in the ionophoretic electrodes, even though care was taken to avoid
these effects.
These problems manifested themselves even more clearly during
attempts to protect the receptors utilizing choline or dTC pipettes.
These experiments required two ionophoretic pipettes, and it proved
impossible to obtain long-term stability.
It is therefore impossible to determine the geometrical extent
of protection in the experiments described in Table I. To obtain one
rough estimate, one can calculate from the rising phase of the drug
potentials, that the ACh and Carb pipettes were located about 10 �
from the nearest receptors (del Castillo and Katz, 1955). In the steady
state, Fick's law states that ACh concentration decreases inversely
with distance from pipette tip. Assuming a transport number of 0.3
and a diffusion constant of 8 x 10-6 cm2/sec f� ACh (del Castillo and
Katz, 1955), the ACh concentration at the receptors was 0.75 mM.
Other experiments (see below, p. 79) show appreciable protection with
concentrations as low as 7 �, or 1/100 of the concentration at the
receptors. Partial protection could therefore have occurred at
distances up to 100 times 10 �, or 1 mm, from the pipette. The
longest endplates attain about this length. It isy therefore, not
surprising that Table I indicates that the entire EPP sometimes
received protection from the Carb or ACh pipettes.
Results with Bath-Applied Protective Drugs
Some uncertainties in the ionophoretic method were overcome by
using bath-applied Carb, dTC, and choline as protective agents.
Protection with Carbamylcholine The first series of experi­
ments confirmed the protection afforded by Carb. Because of the
large scatter among the characteristics of different endplates,
unambiguous protection was obtained only with fairly high doses of




fibers required several hours' washing for a complete recovery from
the reversible blocking agents.
Figure V-3 diagrams a protection experiment, utilizing the
same Carb concentration (0.14 mM) as Figure V-l and a toxin concen­
tration of 1.1 x 10-7 M. Note that a control preparation recovers
completely from the Carb treatment alone. Another preparation shows
an irreversible blockade of 99% of the receptors after toxin alone
(this potency is consistent with the dose-response relationships shown
in Figure IV-2). When the Carb and toxin are applied together, however,
the EPP declines by a much smaller percentage than for toxin alone.
Subsequent applications of toxin alone decreased the EPP by a factor
equal to that of preparations in which the first exposure was to toxin
alone. This observation was repeated on three different muscles and
it confirms the conclusion, drawn from the ionophoretic experiments,
that Carb protects against the toxin. Finally, the last experiment
shows that Carb treatments cannot reverse a block caused by toxin.
Protection with d-Tubocurarine Figure V-4 shows a strictly
analogous experiment utilizing dTC at a concentration (26 �) which
reversibly reduced the EPP to 0.4% of its control level. Toxin concen­
tration was 1.1 x 10-7M, as in the experiments with Carbo As with
Carb, the preparation recovers completely from dTC alone. Furthermore,
dTC seems to protect fibers against simultaneous application of the
toxin. Subsequent application of the toxin to the same fibers, without
protection, causes a decline similar to that observed for the toxin
alone. Like Carb, dTC applied after the toxin does not reverse its
effects.
Differences between Carballo/lcholine and d-Tubocurarine Treatment
At first glance, Figures V-3 and V-4 seem to indicate that dTC and
Carb, in the concentrations used here, protected the receptors equally
against the toxin. Further analysis, however, unearthed a more
complex picture. From the 15 fibers represented by the dTC and Carb















Figure V-3. Protection against cobra toxin by bath-applied Carbo
Each ratio (or set of 2 ratios), ± s.d. represents EPP measurements
on a different muscle. Five identified endplates were sampled at






















B I Wash 3 hr
Figure V-4. Protection against cobra toxin by dTC. See text and
Figure V-3 for details.
EPP amplitude ratios
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nOise, the proximity of the electrode to the endplate, and the MEPP
frequency allowed accurate measurements of MEPP amplitude. These
amplitudes are plotted in Figure V-5 along with EPP amplitudes in
the same fibers. For the Carb protection, the EPP declined by a
significantly greater amount (p < 0.02, by a T-test) than did the
MEPPso For dTC-protected fibers, however, the two ratios are not
significantly different.
Two factors may account for the discrepancy in the Carb case.
First, it would seem, from the recovery of the MEPPs (Fig. V-5),
that the receptors were completely protected by Carb; all the decline
would then arise from a change in quantal content (m). Such a change
would not be surprising (Ciani and Edwards, 1963), especially con­
sidering the long time courses over which the preparation ran. But
such changes did not occur in control preparations treated with Carb
alone (Figure V-3) or with toxin alone (Lester, 1970b; Chapter III).
A second explanation may therefore be considered based upon the fact
that the toxin seems to act asynchronously over an endplate (Chapter
III). The Carb may have protected part of the endplate completely
and part hardly at all. There would thus be a remaining population
of large MEPPs and an apparent decline in m. The data at hand seem
inadequate to decide between these two possibilities.
Quantitative Differences in Protection
I next performed two different experiments to explore the
details of the protecting mechanisms. In the first experiment
(Fig. V-6), doses of Carb, choline, and dTC were selected to reduce
EPPs reversibly to 0.3-0.4 times the original EPP. Toxin was -applied,
as in the experiments shown in Figures V-3 and V-4.
Carb provided significantly greater protection than did dTC,
and choline fell between the two. These data are consistent with
less complete results from preliminary experiments. One must keep















MEPP amplitudes during the protection experiments
(Figs. V-3 and V-4). Ratios, t s.d., represent 8 fibers treated























Figure V-6. EPP amplitude ratios, ± s.d., in each of 3 muscles treated
with different reversible blocking agents. Five identified endplates
in each muscle were sampled at A, At, Band C.
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Nevertheless, the observation of unequal protection appears valid
for the following reasons. Even if Carb decreased m, as suggested
by the earlier experiments, then the actual protection of the
receptors by Carb was even greater than observed, and the difference
between the dTC protection and the Carb protection was even more
marked than the EPP ratios in Figure V-6 indicate.
Choline acts partly as a depolarizing agent (like ACh and Carb)
and partly as a nondepolarizing blocker (like dTC) (del Castillo and
Katz, 1957c; Portela et al., 1970). One therefore expects its pro­
tective properties to lie somewhere between those of Carb and of dTC,
as found experimentally.
Qualitative Differences in Protection
The next experiment (Fig. V-7) strongly supports the idea that
Carb and dTC protect the receptors in qualitatively different fashions.
Carbachol and dTC were used at concentrations which reduced the EPP
to 3-5% of its control value. Although it would have been valuable to
employ choline at doses of comparable potency, the necessary concen-
. tration (about 10 mM) also irreversibly blocked presynaptic ACh
release.
Figure V-7 shows that a remains unchanged from its control
value in the case of dTC block. This observation has been repeated
under many conditions for this and lower dTC concentrations. In
contrast to results obtained at higher dTC concentrations (Fig. V-4),
these data indicate that dTC fails to protect ACh receptors against
cobra toxin (see Discussion for a complete treatment of these
results).
However, in the Carb cas�, the EPP no longer declines
exponentially in time; a must be redefined in accordance with this
interesting new phenomenon (see Discussion). In other preparations
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Figure V-7. Cobra toxin's effects on EPP during partial blockade by
dTC (A) and Carb (B). A different muscle was used for A and B •
• , control run; only toxin was added to the Ringer and was present
between the arrows. ., test run; dTC or Carb was present before,
during, and after toxin treatment.
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toxin still caused the EPP to decline to a plateau in the presence of
Carbo It is worthwhile to emphasize that this behavior seems not to
represent a simple binding equilibrium, because the reversibility in
the presence of Carb is no greater than in the control.
Discussion of the Protection Experiments
In the experiments described above, ACh potentials and EPPs
were measured over a wide amplitude range in response to various drug
and toxin treatments. It is our goal to interpret these data in terms
of drug, toxin, and receptor action.
As a step toward building a model for these experiments, let
us postulate different states of the receptor. These will be defined
in terms of their availability to drugs and, ultimately, in terms of
the ability to produce depolarizations. It would be exceedingly
interesting if we knew how these different states correspond to
molecular alterations in the receptor, perhaps arising from conforma­
tional changes or allosteric interactions. Chapter I gives a review
of recent progress in this field; unhappily, our present knowledge
limits us to operational definitions. Where contact can be made with
other studies of receptor function, this will be noted.
The attack may be summarized before proceeding. We first
present a general kinetic scheme (V-A) for interactions among the
toxin, the receptor, and reversible agonists and antagonists. This
scheme leads to differential equations (V-l). We immediately abandon
the full formmation in order to understand its components. A lengthy
discussion of curarization (Scheme V-B; Eqs. V-2 to V-3) and desensi­
tization (Scheme V-C; E� V-4 to V-5) contrasts the two processes and
casts them into a form amenable to Scheme V-A and E� V-l. We next
discuss the toxin's action as a component of the scheme, essentially
restating the conclusions of Chapter IV.
,I
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Reassembling the pieces, we define the protection parameter r
(Eq. V-8). First treating protection by dTC (Eqs. V-9 to V-12), we
find that its action can be understood only by complicating our
scheme (Scheme V-D). However, the protection by Carb is very well
described by the original formulation (Eqs. V-13 to V-20) , although
the mathematics becomes cumbersome. In particular, the "plateau"
behavior of Figure V-7 is explained as a decay with two time constants,
and some quantitative statements about r are made.
The Kinetic Scheme We define receptor state 1 as the one which
produces depolarization (EPP or drug potentials) when presented with
an agonist. We shall assume that rl, the number of receptors in
state 1, is proportional to the amplitude of EPPs (when we have
controlled for quantal content) or of ACh or Carb potentials. The
justifications for this assumption are presented in Chapter IV.
State 2 is the inactive drug-receptor complex which reverts back to
state I when the complex dissociates. State 3 is the inactive,
irreversible toxin-receptor complex. Let r. be the number of receptors
a
in each state i, and � .. be the rate constant for conversion from state
J�







Note that state 3, the irreversible toxin-receptor complex, can have
no arrows leading from it. The constant called a in Equation IV-lb
becomes a in this scheme.31
This scheme leads to a set of first-order linear differential
equations:
:[01 = - (a2l + a3l)rl + Q' r2, V-Ia12
r2 = a2l rl - (a12 + a32)r2, V-lb
and :[a
3
= a31 r1 + a32 r2• V-lc
It is illuminating to describe two simple cases.
Reversible Block Alone: Desensitization and Curarization First,
in the absence of toxin, a32 = a3l = O. If a reversible blocking agent,
such as ACh, Carb, or dTC, is added to the system, and the initial
condition is rl = s, r2 = 0, a redistribution of receptors will occur.







These equations imply that the system exponentially reaches a new
equilibrium at rl = J..ls; the rate constant is A = a12 + a2l•
In discussing this case, it should be stressed that the molecular
interpretations for the states and rates a vary with the drugs involved.
As mentioned, there are two large classes of reversible blockers, the
agonists and the competitive antagonists (see Chapter I). The agonists,




Figure V-l illustrates desensitization by Carbo The antagonists
merely prevent depolarization.
It is thought that dTC is a "competitive" antagonist, because
it binds reversibly with the ACh receptor site;
k21
R + dTC � R·dTC. V-B
k12




Jenkinson (1960) found that k21/k12 = 2.3 x 10 M for dTC at the
frog sartorius myoneural junction. This value is the "affinity
constant." The determination, utilizing the "dose-ratio" method
(Gaddum et al., 1955), assumed that only one dTC molecule combines
with each receptor and that equal responses correspond to equal
numbers of receptors occupied by the depolarizing drug (ACh or Carb).
Jenkinson also discussed the implications of an ion-exchange reaction
involving the drug and receptor, a concept first proposed by Ing and
Wright (1933) and explored recently in connection with both depolari­
zation and intracellular uptake of cholinergic drugs (Taylor and
Nedergaard, 1965; Taylor et al., 1970)0
For the case of dTC, attempts have been made to measure k21 and
k12 either by the method of micro-ionophoretic application (del
Castillo and Katz, 1957a; Waud, 1967) or by rapid changes « 10 sec)
of the perfusion medium (Goldsmith, 1963; Waud, 1967). Waud in
particular has presented arguments, based on solutions to the
diffusion equations, suggesting that a21 is so large that access to
the receptors limits the onset of dTC block. Although no quantitative
limits are given, it would appear that 1/a21 is less than 100 msec for
doses of dTC which give � � 0.5 --i.e., doses which block more than
half the receptors (see Eq. V-2).
88
This situation, of rapid transitions between receptor states
land 2, contrasts sharply with the desensitization process. Katz�and
Thesleff (1957) studied desensitization by applying ACh and Carb micro­
ionophoretically from one barrel of a double pipette, while monitoring
transient ACh or Carb depolarizations caused by pulses from the other
barrel. The procedure was directly comparable to micro-ionophoretic
application of dTC (del Castillo and Katz, 1957a), but the time course
for the onset of desensitization was many times l�nger than for
curarization. An additional difference was that recovery from
desenSitization, upon cessation of the steady drug release, occurred
with about the same time course as onset. With dTC, on the other hand,
recovery is longer than onset, as predicted by scheme V-B and Eqs. V-3.
Katz and Thesleff (1957) developed a model which explained these
characteristics of desensitization. They postulated a cycle of
receptor states. If A is an agonist molecule,
___ --a- __/",,1




(A + R' AR' )
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The affinity constants a and b govern equilibria which occur within











R is the free receptor; A.R is the active complex which produces
depolarization. The desensitized complex A·R' is incapable of producing
depolarization; R' is the free, desensitized receptor. The two rate
constants Kl and K2 are of the order of fractions of inverse seconds.
Some comments on this model are pertinent. The first is that
the cycle as written requires an energy input. Katz and
Thesleff (1957) considered writing each step as reversible; in that
case, the rate constants lose their independence. After we transform
this cycle into the notation of Scheme V-A, the reader will see that
this distinction will lose its formal, if not its molecular, signifi­
cance. Second, Katz and Thesleff estimated b/a is about 20, so that
appreciable desensitization could occur without sUbstantial depolari­
zation. Finally, the bottom reaction in Scheme V-C confers the pro­
perty of rapid recovery. We shall not consider this feature in our
analysis, because my experiments do not deal with the time course of
recovery.
In Scheme V-C, two compartments I and 2 have been constructed
with dashed lines. These correspond, for the purpose of our analysis,





1 + b [A ]
• V-5b
Summarizing our progress since presenting Scheme V-A, we have
cast both the curarization and desensitization processes into the same
formal mechanism. Both may now be described by Eq� V-2, which are
simplifications of the general Eqs.V-I. We have also seen how the
.'
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formal Scheme V-A relates to known features of the two processes.
In this light, the difference between desensitization and curarization
is a quantitative one. For a given �, the rate constants a21, a12 and
A for desensitization are much smaller--perhaps by a factor of 200-­
than for curarization. This is strikingly evident if one compares the
onset of desensitization in the experiments of Katz and Thesleff (1957)
with the onset of dTC action as seen by del Castillo and Katz (1957a).
Other investigators, primarily using bath-applied Carb, have
confirmed the long time course of desensitization. Nastuk and his
collaborators term the process '�eceptor inactivation" but conclude,
in constrast to Waud (1968), that this is the same phenomenon called
"desensitization" by Thesleff (1955). In general, A in the bath­
applied Carb case is less than with micro-ionophoretic application,
but this difference is ascribed to the fact that ionophoretic pulses
produce a very high local concentration of drug (Nastuk, 1967).
Nastuk and his collaborators studied the effects on desensiti-
zation of Carb concentrations, tonicity of the bathing solution,
divalent cations, and denervation (Manthey, 1966, 1970; Nastuk and
Gissen, 1965; Nastuk and Parsons, 1970). They were impressed that
divalent cations, particularly Ca++ and U02++, produce striking
increases in A for desensitization (Eq. V-2). They therefore proposed
(Nastuk, 1967) that a phosphate-containing macromolecule is bound by
++
Ca to the anionic site of a protein, possibly acetylcholinesterase.
Quaternary ammonium ions compete with Ca++ for the phosphoryl group.
Desensitization occurs when Ca++, possibly from intracellular sources
(Nastuk and Parsons, 1970), displaces the drug from the anionic site
to another, inactive site. Alternatively, the trivalent phosphate
group could be capable of binding several drug molecules; depolarization
would occur if and only if one drug molecule is bound (Nastuk, 1967).
This mechanisms would explain the increase in A with increasing drug
concentration. Nastuk and Parsons (1970) also consider the possibility
that desensitization occurs when free intracellular Ca++ binds with
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anionic sites on the inner surface of the postsynaptic membrane,
somehow resulting in a reduced ionic permeability. Manthey (1970)
offers further evidence for this mechanism based on the time required-­
about 13 sec--for changes in extracellular Ca++ to cause changes in
the rate of desensitization.
Additional evidence for Ca++ interference with ionic permea­
bility arises from experiments with micro-ionophoretic ACh application
(Magazanik and Vyskoci1, 1970). Polyvalent ions were found to
increase the rate of desensitization in the same order that they bind
to phospholipids as well as that in which they affect certain other
nerve membrane resistances. Magazanik and Vyskocil emphasize that
this mechanism for desensitization extends beyond the receptor's
"recognition" function to the "permeation" function
(Chapter 1). This in turn implies that desensitization involves a
more profound change in receptor structure than does curarization--a
conclusion which will be supported by experiments.
These mechanisms, while different from the one proposed by
del Castillo and Katz, may be treated with Scheme V-A and would
therefore result in the kinetics and equilibria described by Eq. V-2.
Toxin Acting Alone. The second simple case is essentially the
experiments reported in Chapters III and IV: the toxin irreversibly
inactivates receptors; no reversible blocking agent is present
(a2l = 0; r2 = 0). All the receptors eventually go to state 3 with
kinetics described by:
V-6
where s is again the original number of receptors. This is the
familiar exponential decline in response amplitude represented by
Figs. III-I, 111-2, 111-3, and IV-I.
In Chapter IV, the rate of toxin action is analyzed. The
conclusion is that the initial stages of toxin action are limited by
92
diffusion of toxin molecules to the vicinity of the receptors; the
toxin concentration near the receptors eventually equals that in the
external bath. At this point the amount of toxin near the receptor
is probably not perturbed by interactions with the receptors or other
muscle components. Pseudo-first order kinetics then prevail, as
described by Eq. V-6. Referring to Eq. IV-lb, we have
V-7
where [T] is toxin concentration and kT is experimentally equal to-4 -1 -15.5'x 10 sec liter mole •
Combined dTC Block and Toxin Treatment We are now in a position
to discuss the results, presented in this chapter, of experiments with
both toxin and reversible blockers of the receptor.
We first consider the case of dTC as the reversible agent. The
experiments lead to the following conclusions: at high dTC concentra­
tions, receptors are partially protected against the toxin. This is
evident from Figure V-4, in which the dTC concentration was 26�. As
defined by Eq. V-2a, � was 0.004. At lower dTC concentrations, there
was no measurable protection. This is evident from Figure V-6([dTC] =
0.5 �; � = 0.3) and Figure V-7 ([dTC] = 5 �; � = 0.03).
These results cannot be readily interpreted in terms of the
general scheme V-A. The question posed by the dTC protection experi­
ment is, can the toxin irreversibly inactivate the curarized (state 2)
as well as the free (state 1) receptor? That is, how does a32 compare
with a31? We may parametrize the amount of protection by taking
V-8
The experiments at � = 0.004 indicate that r < 1, but at � = 0.3 and
0.03, r is approximately one. Scheme V-A, as we have discussed it,
allows for no such influence of � on r.
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Before modifying V-A to fit these observations, it is
important to note how the kinetics of toxin action during reversible
block, as described by Figure V-7, support the conclusion of no pro­
tection at low dTC concentrations. As we have discussed, 1/�12 and
1/�2l for dTC are 0.1 sec or less, depending on the dTC concentration.
On the other hand, l/� for the toxin's action is several minutes.31
Under these conditions, the transitions between states 1 and 2




Since � is smaller than 1, protection is observed during reversible
block as a decrease in the observed rate constant for receptor inacti­
vation. Complete protection (r = 0) would decrease the rate constant
to the fraction�. No decrease showed in the experiments at � = 0.03
(Fig. V-7)� nor was any observed for higher values of �.
Since protection occurred at � = 0.004 (high concentration of
dTC), one would expect to find a decrease in the rate constant for
receptor inactivation under these conditions. However, the high dTC
concentration also meant that the curarized EPP was too small for
reliable kinetic measurements. I had to resort to the experiments
of Figure V-4, which involved EPP measurements before and after, but
not during, dTC treatment.
The simplest way to explain the concentration-dependent
protection by dTC is by an addition to Scheme V-A.
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V - D
We suppose that dTC creates an additional curarized state, which we
label 4. This state may be formed when a second dTC molecule binds to
state "2, whose characteristics have been described. By analogy with
Eq. V-3a, we suppose that
a42 = k42 [dTC] , V-ll
where k42 is a second-order rate constant. By analogy with Eq. V-3b,
a24 is a first-order rate constant. As in the case of a2l and a12,
we suppose that a24 and a42 are large enough so that equilibration
between states 2 and 4 occurs within fractions of a second, although
this point is neither crucial to the discussion nor amenable to
experimentation. At equilibrium,
V-12
and the important point is that the fraction of curarized receptors
in state 4 increases with [dTC]. If state 4 is resistant to the
toxin, this means that a34 <a31• This scheme explains how dTC can
appear to give protection against the toxin only at higher concentra­
tions.
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Is state 4 really an alteration in the receptor produced only
by high concentrations of dTC and other competitive inhibitors, or is
it a major change in the postsynaptic membrane which can arise from
the binding of a large class of molecules? I have little data bearing
on this question, but it should be noted that choline, another
quaternary ammonium compound, produced only slight protection (Fig.
V-6) at concentrations 50 times greater than the dTC concentrations in
Figure V-4. In connection with this point, it would be interesting
to measure the protection afforded by other strychnos alkaloids which
are not cholinergic blocking agents (Taylor and Nedergaard, 1965).
Combined Carb Block and Toxin Treatment In contrast to the
fitful protection provided by dTC, Carb protected the receptor against
cobra toxin at all concentrations tested, from 7 � (� = 0.4) to
140 � (�= 0.005).
The kinetics shown in the lower part 9f Figure V-7 are an
interesting aspect of the toxin's action during Carb protection.
Scheme V-A can explain this data. We begin by reviewing the experi­
mental procedure. Before addition of toxin, the preparation has been
desensitized by a steady concentration of Carbo This situation is
described by E� V-2. If the original number of receptors was s,
the new size of rl is �s.
When toxin is added in the presence of Carb, Equations V-l hold.
The general solution in terms of the measurable quantity, r1, is
-x t









The values for �± may be determined by noting that, for t = 0,
� +� =J..1s ..+ - V-1Sa
Also, from Eq. V-la, at t = 0,
V-1Sb
The simultaneous linear equations V-15 solve as follows:
a -a -a -a
�l 31 21 12 32�± = 2'- t. Q J. V-16
Thus, Eqs. V-l predict an exponential decline to zero with two time







This plot has the same shape as the experimental run in Figure
V-7. A brief argument will be given here to show that the quantitative
features of Figure V-7 can be predicted from Equations V-13 to V-16
and reasonable values for a12, a2l, a3l, and a32• First, Equations
V-2b and V-2c may be used for a determination of a12, a2l, if we have
a value for A for desensitization alone.
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There are no experiments in the literature with [ca++] = 2 M and
[Carb] = 56 �M, as in Figure V-7, but Manthey (1970) reports a half
time (= O.�93) of 55 sec for [Ca++] = 1.8 �� and [Carb] = 137 �.This resu t was obtained in potassium-depolarized fibers, and the
transformation to normal resting potential is uncertain (Magazanik
and Vyskocil, 1970)J. Manthey's results and those of Katz and
Thesleff (see Eq. V-7a) indicate that A increases less than linearly
with {CarbJ. I therefore estimate that the half-time for desensiti­
zation in my experiments was 100 sec, giving A = 7 x 10-3 sec-I.
As mentioned, � in my experiments was 0.03. Therefore, from Equations
V-2b, V-2c,
= 2.3 x 10-4 -Isec�12
�21 = 6.B x 10-3
-1
sec
Next, the value for �3l is just the slope of the control run in
-3 -1
the lower part of Figure V-7b, or 3.3 x 10 sec •
Finally, �32 represents the vulnerability of the desensitized
receptor to the toxin and is therefore a most interesting parameter.
The data in Figures V-3, V-5, V-6 and V-7 all suggest that a32 <�31.
As in the discussion of dTC protection (Eq. V-B), we let a32 = ra3l•
A decay with two time constants occurs only for r < 1, which corresponds
to protection. Predicted and observed values of A and � are given� t
in Table III as a function of r.
Considering the uncertainties in a12, a21 and the fact that
Equation V-16 involves strong cancellation among the values for a,
the agreement between theory and experiment is good. The chief effect
of increasing r is to increase A_, the slope of the slow decay. The
data seem inconsistent with r greater than 0.1. Therefore, protection
seems nearly complete. However, this kinetic data still leaves open
the possibility that desensitized receptors retain a small vulner­
ability to the toxin.
The experiments in Figures V-3, V-5, V-6, approach this point
by utilizing the fact that states 2 and 3 are distinguished from each
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Table III
Kinetics of receptor inactivation by toxin during Carb treatment,
according to experiment and as predicted by Scheme V-A and Equations





A. ,sec A_' sec �+ Q, sec+
(xl03) (xl03) � � (xl03)
Experiment (Fig. V-7) >5 < 0.5 0.75 0.25
Predicted: 1 = 0 10.6 0.2 0.30 0.70 10.35
1 = 0.1 10.8 0.7 0.27 0.73 10.1
'1 = 0.5 10.6 1.8 0.17 0.83 8.9
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other on the basis of reversibility. Upon washing out the agonist,
all the receptors in state 2 should revert to state 1, and r3 may be
determined by subtraction from s. In general, Equations V-l solve
for r3 in terms of the same A+' A_. Remembering that r3 = 0, rl = �s,
and r2 = (l-�)s at t = 0, and r3 = s at t = 00, we have
V-17
The initial conditions give
V-IBa
and, from Eq. V-lc,
V-IBb
Equations V-IB solve for
= �[l + (1-2�)(a31
- a32) + a12 + a21].
Q
V-19
Figures V-3 and V-5 illustrate the difficulties in actual
application of Equations V-17, V-18, and V-19. The recovery from
treatment with large Carb concentration is erratic and may involve
permanent changes in quantal content. If one looks at protection
of MEPP instead of EPP amplitudes, in order to eliminate presynaptic
effects, Figure V-5 suggests that desensitized receptors received
nearly complete protection. We therefore adopt the value s -. r3 = 0090
-3 -1
s
From Equation V-7, a = 6.05 x 10 sec • We again utilize
Manthey's (1966, 197tl} measurements on the kinetics of desensitization
to estimate A = 1.26 x 10-2 sec-l (Eq. V-2). In these experiments,
� was too small to measure; we adopt the upper limit, � = 0.005.
Then, by Equation V-2c
5 3 10-5 -1a12 = . x sec
100
�e next determine a ,a21 for the experiment of Figure V-6.No stud1es appear in the Iltera�ure for the time course of desensi­
tization with Carb concentrations as low as these (7 �). On the
basis of preliminary data, I estimate A = 3 x 10-3 sec-I. For � =
0.4, Equations V-2 give
�12 = 1.2 x 10-3 sec-l
a2l = 1.S x 10-3
-1
sec
No permanent effect on quantal content was noticeable in this experi­
ment.
Table IV compares results of these two experiments with pre­
s-r
dicated values for 3 on the basis of a variable r and Equations
s
V-17, V-lS, and V-19. Again the data are fit well by r = 0.1 or less.
Like the kinetic data, these experiments are consistent with nearly
complete protection in the desensitized state.
In the future, it may prove possible to identify r with the
fine structure of state 2. For instance, referring to Scheme V-C, R'
might be as vulnerable to the toxin as R, but AR and AR' completely
resistant. By Equations V-4 and V-5, this leads to
_ �
R • ]1 ( [R .] + [AR']) _ 1 + a [A]r - RJ/ ([R ] + [AR J)
-
1 + b [Ar
V-20
We have little basis on which to explore this model in detail. But
it does predict that r will approach the lower limit, �, for large
b
values of A. It also allows an estimate of a, the Carb affinity of
the ACh receptor. Taking � = 0.05 (Katz and Thesleff, 1957) and
b
r = 0.1 at [CarbJ_= 7 �M (Table IV), Equation V-20 solves for _
a = 1.3 x 105 M-l• This value agrees with the results of other work
(Fatt, 1950; del Castillo and Katz, 1957b. For a rigorous discussion
of methods for determining a, see Furchgott, 1964; and Waud, 1965).
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Table IV
Carb protection against cobra toxin, 1.1 x 10-7 M. Details of the
calculations and assumptions are given in the text.
See Fig. [CarbJ s-r3 observed s-r3 predicted rJ.l
s, s,
V-3,V-5 140J.,J.M 5xlO-3 0.9
0.99 0
0.82 0.1






These experiments involved micro-ionophoretic applications of
agonists (ACh and Carb) and bath application of an agonist (Carb) and
a competitive antagonist (dTC). It was shown that focal application
of agonists provides focal protection against cobra toxin. According
to a simple model (V-A), the bath-applied agonists also provided
nearly complete protection (r <0.1) in the desensitized state.
Furthermore, it was shown that the model accounts for interesting
two-stage kinetics of toxin action (Fig. V-7) when one takes account
of the slow rate constants for entering and leaving the desensitized
state.
For the competitive inhibitor, dTC, the model requires modifi­
cation (Scheme V-D) so that protection occurs only when high concen­
trations of dTC produce a new receptor state.
The experiments therefore imply that agonists produce a rather
more profound change in receptor structure than do competitive antagon­
ists. Current concepts of drug action would seem to agree. Of some
relevance are the conclusions of Nastuk and Parsons (1970), Manthey
(1970), and Magazanik and Vyskocil (1970), that desensitization
interferes with the "permeation" function of the receptor in addition
to the "recognition" function (Chapter I, pp. 2 - 6). Likewise,
Changeux and Podleski (1968) found that agonists, but not competitive
antagonists, produce changes in the co-operative properties of the
postsynaptic membrane.
The present model (V-A) sheds some light on the "metaphilic"
reagents (Rang and Ritter, 1969). Their action has been interpreted
as arising from a greater reactivity for the desensitized than for
the normal receptor. In terms of Scheme V-A and Equation V-8, we
may say that, for metaphilic reagents, ., > 1.
The present analysis also shares features with that of
Steinbach (1968a, b), who studied processes with rate constants several
"
103
orders of magnitude faster than the ones I have considered. Steinbach
found that Xylocaine and its derivatives alter the time course of
EPPs and ACh potentials by reducing the early phase of the endplate
current and prolonging its later phase. Like the effects I have
described, this behavior was shown to arise from differences in a





I initiated this study in order to establish cobra toxin as
a comprehensible pharmacological tool for investigations of cholin­
ergic transDUssion. My work fell naturally into three major
divisions. First, I showed that the toxin's action is confined to
the postsynaptic nicotinic acetylcholine (ACh) receptor (Chapter III).
Second, I showed that this action probably involves an irreversible
monomolecular binding to the receptor (Chapters IV and V). Finally,
I have begun to use the toxin as a probe for distinguishing various
states of the receptor (Chapter V).
One important hope underlying my investigation was that we
could understand these toxins well enough to employ them as biochemical
markers for isolating the ACh receptor. This hope has recently
received encouragement from studies involving a-bungarotoxin, the
closely related toxin from the Formosan krait (see Table I). One
group (Changeux et al., 1970) has followed the binding of pharmaco­
logical agents to a partially purified protein which fulfills many
criteria for the receptor. Bungarotoxin inhibits this binding in the
same fashion one would predict from the electrophysiological results.
Another group (Miledi et a1., 1971) has also described, experi­
ments which led to a partial purification of the receptor. In this
131
b t' 1 b 1 f 11 d thr hcase, a bound I �- ungaro OX1n a e was 0 owe oug
isolation procedures. These investigators also briefly report results
which corroborate my finding, that desensitization protects the
receptor against the toxin more completely than does curarization.
One expects that such studies will soon bear fruit in two areas.
First, with the isolated receptor in hand, we shall be able to investi­
gate the molecular mechanism by which ACh induces ionic permeability
changes in postsynaptic structures. Second, we shall have the proper
tool to study the biology of synaptic plasticity and development.
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